https://curecurrent.com/trials/a-cohort-study-on-the-prevention-of-nausea-and-vomiting-induced-by-concurrent-chemoradiotherapy-for-lung-cancer-using-ro-44001https://curecurrent.com/trials/single-fraction-pulmonary-ablative-radiotherapy-outcomes-and-quality-of-life-workup-44002https://curecurrent.com/trials/intrathecal-injection-pemetrexed-and-bevacizumab-in-patients-with-leptomeningeal-metastases-in-nsclc-44003https://curecurrent.com/trials/anlotinib-plus-whole-brain-radiotherapy-for-brain-metastases-in-sclc-patients-44004https://curecurrent.com/trials/positron-emission-tomography-pet-imaging-of-thrombosis-44005https://curecurrent.com/trials/phase-ii-trial-to-modulate-intermediate-endpoint-biomarkers-in-former-and-current-smokers-44006https://curecurrent.com/trials/golidocitinib-with-pd-1-inhibitors-as-maintenance-treatment-for-previously-untreated-es-sclc-44007https://curecurrent.com/trials/18f-pd-l1-pet-ct-in-nivolumab-treated-patients-with-nsclc-44008https://curecurrent.com/trials/efficacy-and-safety-of-standard-of-care-plus-durvalumab-in-patients-with-limited-disease-small-cell-lung-cancer-dolphin-44009https://curecurrent.com/trials/fdg-pet-ct-in-lung-cancer-staging-44010https://curecurrent.com/trials/promoting-immunotherapy-efficacy-with-low-dose-liver-rt-44011https://curecurrent.com/trials/a-multinational-study-assessing-an-oral-egfr-inhibitor-dzd6008-in-patients-who-have-advanced-nsclc-with-egfr-mutations-t-44012https://curecurrent.com/trials/to-assess-the-effectiveness-and-safety-of-zepzelca-in-adult-patients-with-extensive-stage-small-cell-lung-cancer-sclc-44013https://curecurrent.com/trials/a-study-to-assess-naporafenib-eras-254-administered-with-trametinib-in-patients-with-ras-q61x-mutations-44014https://curecurrent.com/trials/evaluation-of-pet-probe-68ga-cbp8-in-the-detection-of-radiation-induced-tissue-injury-44015https://curecurrent.com/trials/molecularly-targeted-radionuclide-therapy-via-the-integrin-alphavbeta6-44016https://curecurrent.com/trials/preliminary-evaluation-of-68ga-cbp8-in-healthy-individuals-lung-cancer-and-idiopathic-pulmonary-fibrosis-patients-44017https://curecurrent.com/trials/sublobar-wedge-resection-or-stereotactic-radiotherapy-treatment-of-high-risk-patients-with-early-stage-lung-cancer-44018https://curecurrent.com/trials/induction-chemotherapy-and-toripalimab-followed-by-chemoradiotherapy-for-large-volume-local-advanced-nsclc-44019https://curecurrent.com/trials/fluorine-18-alphavbeta6-binding-peptide-positron-emission-tomography-in-metastatic-non-small-cell-lung-cancer-44020https://curecurrent.com/trials/study-of-risk-factors-and-prediction-of-blood-clots-after-lung-cancer-surgery-44021https://curecurrent.com/trials/a-real-world-study-evaluating-the-efficacy-and-safety-of-adebrelimab-in-patients-with-advanced-sclc-44022https://curecurrent.com/trials/pd-1-inhibitor-and-chemotherapy-with-concurrent-irradiation-at-varied-tumour-sites-in-advanced-non-small-cell-lung-cance-44023https://curecurrent.com/trials/comparing-smoking-cessation-interventions-among-underserved-patients-referred-for-lung-cancer-screening-44024https://curecurrent.com/trials/a-study-of-tak-788-in-adults-with-non-small-cell-lung-cancer-44025https://curecurrent.com/trials/erector-spinae-block-for-thoracic-surgery-44026https://curecurrent.com/trials/carbon-nanoparticle-loaded-iron-in-the-treatment-of-advanced-solid-tumor-44027https://curecurrent.com/trials/image-guided-hypofractionated-radiation-therapy-with-stereotactic-body-radiation-therapy-boost-and-combination-chemother-44028https://curecurrent.com/trials/extended-reality-xr-assisted-ct-localization-of-pulmonary-nodules-44029https://curecurrent.com/trials/ifinatamab-deruxtecan-i-dxd-in-subjects-with-pretreated-extensive-stage-small-cell-lung-cancer-es-sclc-44030https://curecurrent.com/trials/a-study-of-pembrolizumab-mk-3475-with-or-without-maintenance-olaparib-in-first-line-metastatic-squamous-non-small-cell-l-44031https://curecurrent.com/trials/comparative-analysis-between-thymic-pulmonary-and-pancreatic-well-differentiated-high-grade-neuroendocrine-tumors-44032https://curecurrent.com/trials/bevacizumab-combined-with-double-doses-of-icotinib-in-advanced-nsclc-patients-with-egfr-l858r-mutation-44033https://curecurrent.com/trials/functional-lung-avoidance-spect-guided-radiation-therapy-of-lung-cancer-44034https://curecurrent.com/trials/self-management-survivorship-care-in-stage-i-iii-non-small-cell-lung-cancer-or-colorectal-cancer-44035https://curecurrent.com/trials/understanding-the-post-surgical-non-small-cell-lung-cancer-patient-s-symptom-experience-44036https://curecurrent.com/trials/combo-endoscopy-oropharyngeal-airway-in-sedated-fiberoptic-bronchoscopy-for-patients-a-simon-two-stage-trial-44037https://curecurrent.com/trials/a-study-in-participants-with-advanced-cancers-associated-with-expression-of-dll3-mk-6070-001-hpn328-4001-44038https://curecurrent.com/trials/remimazolam-for-bronchoscopy-in-high-risk-patients-44039https://curecurrent.com/trials/tislelizumab-combined-with-chemotherapy-followed-by-thoracic-consolidation-radiotherapy-in-the-first-line-treatment-of-e-44040https://curecurrent.com/trials/pre-operative-tumor-treating-fields-in-patients-with-resectable-lung-cancer-44041https://curecurrent.com/trials/cish-inactivated-tils-in-the-treatment-of-nsclc-44042https://curecurrent.com/trials/a-study-to-learn-about-how-different-amounts-of-the-study-medicine-pf-07826390-act-in-the-body-of-people-with-cancer-whe-44043https://curecurrent.com/trials/a-study-of-trastuzumab-deruxtecan-in-people-with-non-small-cell-lung-cancer-44044https://curecurrent.com/trials/mid-point-transverse-process-to-pleura-block-versus-thoracic-paravertebral-block-in-posterolateral-thoracotomy-44045https://curecurrent.com/trials/a-study-comparing-abelacimab-to-apixaban-in-the-treatment-of-cancer-associated-vte-44046https://curecurrent.com/trials/precision-lung-cancer-survivorship-care-intervention-44047https://curecurrent.com/trials/exploration-of-circulating-micrornas-as-biomarkers-of-chemo-induced-peripheral-neuropathy-a-study-in-cancer-patients-44048https://curecurrent.com/trials/lung-cancer-screening-in-high-risk-black-individuals-44049https://curecurrent.com/trials/early-rebiopsy-to-identify-biomarkers-of-tumor-cell-survival-following-egfr-alk-ros1-or-braf-tki-therapy-44050https://curecurrent.com/trials/empowering-patients-lung-cancer-screening-uptake-44051https://curecurrent.com/trials/poziotinib-in-egfr-exon-20-mutant-advanced-nsclc-44052https://curecurrent.com/trials/partial-tumor-irradiation-and-immunotherapy-for-unresectable-lung-cancer-44053https://curecurrent.com/trials/multimedia-self-management-intervention-for-lung-cancer-surgery-family-caregivers-and-patients-44054https://curecurrent.com/trials/nivolumab-plus-cisplatin-pemetrexed-or-cisplatin-gemcitabine-as-induction-in-resectable-non-small-cell-lung-cancer-44055https://curecurrent.com/trials/the-effect-of-motivational-nterviewing-on-ntention-to-quit-smoking-in-lung-cancer-patients-44056https://curecurrent.com/trials/testing-the-safety-of-dapagliflozin-prior-to-surgery-for-the-treatment-of-patients-with-stage-ia-lung-adenocarcinoma-44057https://curecurrent.com/trials/veterans-affairs-lung-cancer-surgery-or-stereotactic-radiotherapy-44058https://curecurrent.com/trials/efficacy-and-safety-study-of-pembrolizumab-mk-3475-with-or-without-lenvatinib-mk-7902-e7080-in-adults-with-programmed-ce-44059https://curecurrent.com/trials/azd1775-plus-carboplatin-paclitaxel-in-squamous-cell-lung-cancer-44060https://curecurrent.com/trials/pf-07265028-as-single-agent-and-in-combination-with-sasanlimab-in-advanced-or-metastatic-solid-tumors-44061https://curecurrent.com/trials/advancing-lung-cancer-screening-one-text-at-a-time-44062https://curecurrent.com/trials/a-phase-1-study-of-mrtx0902-in-solid-tumors-with-mutations-in-the-kras-mapk-pathway-44063https://curecurrent.com/trials/phase-1-2-study-evaluating-mcla-129-a-human-anti-egfr-anti-c-met-bispecific-antibody-in-advanced-nsclc-and-other-solid-t-44064https://curecurrent.com/trials/molecular-analysis-of-oncogenes-and-resistance-mechanisms-in-lung-cancer-44065https://curecurrent.com/trials/discrimination-of-n2a-and-n2b-by-ebus-tbna-is-a-change-of-the-needle-necessary-44066https://curecurrent.com/trials/a-multicenter-open-label-phase-ii-study-of-cemiplimab-plus-chemotherapy-selected-on-the-basis-of-baseline-cytidine-deami-44067https://curecurrent.com/trials/fanlung-2-the-value-of-high-low-mixed-dose-radiotherapy-combined-with-chemo-immunotherapy-induction-in-locally-advanced-44068https://curecurrent.com/trials/correlation-of-lung-ultrasonography-with-chest-ct-findings-in-cancer-patients-with-covid-19-viral-pneumonia-44069https://curecurrent.com/trials/mk-3475-and-gemcitabine-in-non-small-cell-lung-cancer-nsclc-44070https://curecurrent.com/trials/a-real-world-study-of-pralsetinib-combined-with-leucogen-in-the-treatment-of-ret-fusion-positive-nsclc-44071https://curecurrent.com/trials/study-of-cp-383-in-patients-with-advanced-or-metastatic-solid-tumors-44072https://curecurrent.com/trials/expanded-access-to-mifomelatide-for-cachexia-in-adults-with-advanced-pdac-44073https://curecurrent.com/trials/a-study-to-learn-about-brigatinib-treatment-information-available-in-chinese-participants-with-non-small-cell-lung-cance-44074https://curecurrent.com/trials/exercise-rehabilitation-in-veteran-cancer-survivors-44075https://curecurrent.com/trials/development-and-clinical-validation-of-early-stage-lung-cancer-prognostic-kit-44076https://curecurrent.com/trials/a-clinical-study-for-the-efficacy-and-safety-of-bl0020-injection-in-patients-with-small-cell-lung-cancer-transformed-fro-44077https://curecurrent.com/trials/partial-pleurectomy-surgery-for-unresectable-pleural-mesothelioma-44078https://curecurrent.com/trials/predictive-value-of-a-preliminary-swallowing-test-compared-to-postoperative-nasofibroscopy-to-identify-vocal-cord-paraly-44079https://curecurrent.com/trials/limertinib-plus-radiotherapy-for-egfr-mutant-nsclc-with-brain-metastases-44080https://curecurrent.com/trials/leucoselect-phytosome-for-neoadjuvant-treatment-of-early-stage-lung-cancer-44081https://curecurrent.com/trials/a-phase-ib-study-of-hs-10504-combined-therapy-in-nsclc-44082https://curecurrent.com/trials/culturally-tailored-educational-video-to-promote-lung-cancer-screening-in-vulnerable-communities-44083https://curecurrent.com/trials/effects-of-bright-light-exposure-combined-with-specific-exercise-training-best-program-in-patients-with-cancer-44084https://curecurrent.com/trials/liver-surgery-and-chemotherapy-in-treating-patients-with-colorectal-cancer-with-liver-metastases-that-can-be-removed-by-44085https://curecurrent.com/trials/integrative-multi-omics-and-functional-platform-for-the-complete-diagnostic-characterization-of-tumors-the-italian-tumor-44086https://curecurrent.com/trials/alt-803-plus-nivolumab-in-patients-with-pretreated-advanced-or-metastatic-non-small-cell-lung-cancer-44087https://curecurrent.com/trials/formatting-the-risk-prediction-models-for-never-smoking-lung-cancer-44088https://curecurrent.com/trials/a-phase-i-study-to-evaluate-the-safety-and-preliminary-efficacy-of-225ac-ac-dotatate-injection-combined-with-tislelizuma-44089https://curecurrent.com/trials/a-study-to-investigate-the-safety-and-tolerability-of-intravenous-qeq278-in-patients-with-advanced-solid-tumors-44090https://curecurrent.com/trials/tobacco-education-and-lung-health-study-teal-44091https://curecurrent.com/trials/study-of-the-cdk4-6-inhibitor-palbociclib-pd-0332991-in-combination-with-the-pi3k-mtor-inhibitor-gedatolisib-pf-05212384-44092https://curecurrent.com/trials/evaluating-the-impact-of-a-virtually-supervised-exercise-intervention-and-group-counseling-on-inflammation-and-the-micro-44093https://curecurrent.com/trials/ibi363-pd-1-il-2-bias-in-combination-with-chemotherapy-as-neoadjuvant-therapy-in-initially-unresectable-stage-iii-non-sm-44094https://curecurrent.com/trials/shape-sensing-robotic-assisted-bronchoscopy-for-diagnosis-of-peripheral-pulmonary-nodules-in-korea-44095https://curecurrent.com/trials/study-of-rp1-monotherapy-and-rp1-in-combination-with-nivolumab-ignyte-44096https://curecurrent.com/trials/ctdna-monitoring-guides-the-treatment-of-nsclc-with-befotertinib-combined-with-radiotherapy-44097https://curecurrent.com/trials/tubeless-strategy-for-enhanced-recovery-after-sublobar-resection-44098https://curecurrent.com/trials/sarcopenia-and-cachexia-in-patients-with-lung-cancer-44099https://curecurrent.com/trials/preoperative-structured-exercise-programme-on-patients-with-non-small-cell-lung-cancer-44100https://curecurrent.com/trials/rucaparib-and-pembrolizumab-for-maintenance-therapy-in-stage-iv-non-squamous-non-small-cell-lung-cancer-44101https://curecurrent.com/trials/low-dose-interleukin-2-and-pembrolizumab-for-the-treatment-of-stage-iv-non-small-cell-lung-cancer-44102https://curecurrent.com/trials/implementing-spiritual-care-in-inpatient-palliative-care-44103https://curecurrent.com/trials/study-of-early-cancer-biomarkers-in-breath-condensate-in-population-of-individuals-with-high-risk-of-lung-cancer-undergo-44104https://curecurrent.com/trials/local-ablative-therapy-to-oligoresidual-metastasis-in-egfr-mutated-non-small-cell-lung-cancer-44105https://curecurrent.com/trials/diclofenac-for-the-treatment-of-patients-with-metastatic-non-small-cell-lung-cancer-on-single-agent-immunotherapy-44106https://curecurrent.com/trials/livewell-adapted-dbt-skills-training-for-metastatic-lung-cancer-44107https://curecurrent.com/trials/niraparib-temozolomide-and-atezolizumab-in-treating-patients-with-advanced-solid-tumors-and-extensive-stage-small-cell-l-44108https://curecurrent.com/trials/durvalumab-after-concurrent-chemoradiotherapy-ccrt-for-limited-stage-small-cell-lung-cancer-ls-sclc-44109https://curecurrent.com/trials/stereotactic-body-radiotherapy-sbrt-for-reirradiation-of-inoperable-lung-lesions-44110https://curecurrent.com/trials/study-of-palbociclib-in-combination-with-binimetinib-for-patients-with-advanced-kras-mutant-non-small-cell-lung-cancer-44111https://curecurrent.com/trials/neoadjuvant-platform-trial-in-non-small-cell-lung-cancer-44112https://curecurrent.com/trials/study-of-probiotics-combined-with-concurrent-hyperfractionated-chemoradiotherapy-and-adebrelimab-immunomaintenance-in-th-44113https://curecurrent.com/trials/a-prospective-phase-ii-clinical-study-of-immunotherapy-combined-with-chemotherapy-for-stage-iii-unresectable-non-small-c-44114https://curecurrent.com/trials/ibi363-as-neoadjuvant-therapy-in-resectable-stage-ii-iii-non-small-cell-lung-cancer-44115https://curecurrent.com/trials/tarlatamab-vs-standard-of-care-chemotherapy-in-patients-with-pre-treated-advanced-pulmonary-or-gastroenteropancreatic-po-44116https://curecurrent.com/trials/sars-cov-2-vaccine-geo-cm04s1-versus-mrna-sars-cov-2-vaccine-in-patients-with-blood-cancer-44117https://curecurrent.com/trials/a-study-of-calderasib-mk-1084-with-midazolam-and-digoxin-in-healthy-participants-mk-1084-009-44118https://curecurrent.com/trials/validation-of-high-throughput-large-format-tissue-preprocessing-for-lung-and-colorectal-cancer-44119https://curecurrent.com/trials/noninvasive-detection-of-lung-nodule-malignancy-using-cfdna-fragmentomics-44120https://curecurrent.com/trials/complications-associated-with-lymphadenectomy-lad-in-surgical-treatment-of-non-small-cell-lung-cancer-nsclc-44121https://curecurrent.com/trials/anlotinib-in-cross-line-treatment-of-nsclc-and-sclc-44122https://curecurrent.com/trials/comparison-of-serplulimab-versus-nivolumab-in-neoadjuvant-therapy-for-resectable-stage-ii-iiia-squamous-nsclc-44123https://curecurrent.com/trials/study-of-mcla-129-a-human-bispecific-egfr-and-cmet-antibody-in-patients-with-advanced-nsclc-and-other-solid-tumors-44124https://curecurrent.com/trials/korea-post-marketing-surveillance-pms-study-of-vizimpro-44125https://curecurrent.com/trials/adebrelimab-combined-with-oral-etoposide-for-elderly-patients-and-patients-with-poor-performance-status-in-small-cell-lu-44126https://curecurrent.com/trials/specimens-for-lung-cancer-panel-design-44127https://curecurrent.com/trials/pet-ct-imaging-to-evaluate-cardiac-radiation-damage-in-patients-with-lung-or-esophageal-cancer-euclid-trial-44128https://curecurrent.com/trials/efficacy-safety-and-pharmacodynamics-of-tislelizumab-monotherapy-and-multiple-tislelizumab-based-immunotherapy-combinati-44129https://curecurrent.com/trials/functional-lung-avoidance-radiotherapy-guided-by-4dct-pulmonary-ventilation-function-imaging-a-prospective-single-arm-cl-44130https://curecurrent.com/trials/an-open-label-phase-1-2-study-of-itacitinib-in-combination-with-osimertinib-in-subjects-with-non-small-cell-lung-cancer-44131https://curecurrent.com/trials/non-intubated-versus-intubated-anesthesia-for-thoracoscopic-sublobar-resection-44132https://curecurrent.com/trials/study-of-the-immunity-of-patients-with-lung-cancer-and-covid-19-infection-44133https://curecurrent.com/trials/multicenter-phase-ii-randomized-controlled-study-of-adebrelimab-combined-with-chemotherapy-and-concurrent-low-dose-radio-44134https://curecurrent.com/trials/radiation-therapy-to-relieve-symptoms-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-44135https://curecurrent.com/trials/a-study-of-vobramitamab-duocarmazine-in-participants-with-metastatic-castration-resistant-prostate-cancer-and-other-soli-44136https://curecurrent.com/trials/a-prospective-cohort-study-of-zorifertinib-as-a-first-line-treatment-in-patients-with-epidermal-growth-factor-receptor-m-44137https://curecurrent.com/trials/application-of-4dct-based-pulmonary-ventilation-imaging-in-lung-cancer-radiotherapy-44138https://curecurrent.com/trials/hybrid-robot-assisted-percutaneous-ablation-and-non-intubated-vats-for-multiple-pulmonary-nodules-44139https://curecurrent.com/trials/atezolizumab-versus-atezolizumab-plus-bevacizumab-as-first-line-in-nsclc-patients-beat-44140https://curecurrent.com/trials/ysqtg-combined-with-immuno-chemotherapy-for-extensive-stage-small-cell-lung-cancer-44141https://curecurrent.com/trials/efficacy-and-safety-of-t-dxd-in-her2-mutant-advanced-lung-cancer-patients-with-asymptomatic-brain-metastases-44142https://curecurrent.com/trials/post-market-study-of-transbronchial-cryo-assisted-rfa-during-robotic-bronchoscopy-with-subsequent-surgical-resection-44143https://curecurrent.com/trials/a-study-of-ab-106-in-subjects-with-advanced-nsclc-harboring-ros1-fusion-gene-44144https://curecurrent.com/trials/characteristics-of-sexual-dysfunction-in-patients-with-lung-cancer-44145https://curecurrent.com/trials/a-study-for-identification-of-predictive-immune-biomarker-for-atezolizumab-therapy-in-nsclc-patients-44146https://curecurrent.com/trials/a-phase-i-study-of-alps12-in-patients-with-extensive-stage-small-cell-lung-cancer-44147https://curecurrent.com/trials/intratumoral-cisplatin-for-resectable-nsclc-44148https://curecurrent.com/trials/survivin-long-peptide-vaccine-in-treating-patients-with-metastatic-neuroendocrine-tumors-44149https://curecurrent.com/trials/phase-ii-trial-of-amivantamab-plus-monochemotherapy-in-platinum-unfit-nsclc-patients-with-egfr-exon20-insertion-mutation-44150https://curecurrent.com/trials/peripheral-blood-etasts-for-predicting-efficacy-of-chemoimmunotherapy-in-nsclc-44151https://curecurrent.com/trials/durvalumab-and-grid-therapy-for-non-small-cell-lung-cancer-in-progression-during-or-after-treatment-with-pacific-regimen-44152https://curecurrent.com/trials/integrating-smoking-cessation-with-low-dose-ct-screening-for-lung-cancer-44153https://curecurrent.com/trials/lung-cancer-radiotherapy-using-realtime-dynamic-multileaf-collimator-mlc-adaptation-and-radiofrequency-tracking-44154https://curecurrent.com/trials/pathological-response-after-neoadjuvant-treatment-on-nsclc-44155https://curecurrent.com/trials/treatment-for-advanced-non-small-cell-lung-cancer-with-actionable-genomic-alterations-after-targeted-treatment-and-chemo-44156https://curecurrent.com/trials/efficacy-of-tedopi-plus-docetaxel-or-tedopi-plus-nivolumab-as-second-line-therapy-in-metastatic-non-small-cell-lung-canc-44157https://curecurrent.com/trials/pbf-1129-and-nivolumab-for-the-treatment-of-recurrent-or-metastatic-non-small-cell-lung-cancer-44158https://curecurrent.com/trials/a-study-of-abemaciclib-ly2835219-in-participants-with-previously-treated-kras-mutated-lung-cancer-44159https://curecurrent.com/trials/assessing-the-system-for-high-intensity-evaluation-during-radiotherapy-during-changes-in-response-to-covid-19-44160https://curecurrent.com/trials/atezolizumab-and-varlilumab-in-combination-with-radiation-therapy-for-nsclc-44161https://curecurrent.com/trials/assess-diversity-of-gut-microbiome-in-met-nsclc-in-correlation-to-tx-adverse-effects-44162https://curecurrent.com/trials/daily-adaptive-radiation-therapy-an-individualized-approach-for-stage-iii-lung-cancer-44163https://curecurrent.com/trials/brain-oligometastasis-in-nsclc-44164https://curecurrent.com/trials/gemini-nsclc-nsclc-biomarker-study-44165https://curecurrent.com/trials/safety-and-immunogenicity-of-9-valent-human-papillomavirus-9vhpv-vaccine-coadministered-with-messenger-ribonucleic-acid-44166https://curecurrent.com/trials/safety-and-efficacy-analysis-of-oral-etoposide-combined-with-anlotinib-and-envafolimab-in-first-line-treatment-of-elderl-44167https://curecurrent.com/trials/safety-and-efficacy-study-of-pemetrexed-platinum-chemotherapy-pembrolizumab-mk-3475-with-or-without-lenvatinib-mk-7902-e-44168https://curecurrent.com/trials/study-of-225ac-ss0110-in-subjects-with-es-sclc-or-mcc-santana-225-44169https://curecurrent.com/trials/zipalertinib-with-carboplatin-and-pemetrexed-for-the-treatment-of-resectable-stage-ii-iiib-non-small-cell-lung-cancer-44170https://curecurrent.com/trials/intrapleural-photodynamic-therapy-in-a-multimodal-treatment-for-patients-with-malignant-pleural-mesothelioma-44171https://curecurrent.com/trials/percutaneous-robotic-navigation-microwave-ablation-versus-ct-guided-microwave-ablation-in-the-treatment-of-pulmonary-nod-44172https://curecurrent.com/trials/the-effect-of-preoperative-education-on-recovery-of-thoracic-surgery-patients-44173https://curecurrent.com/trials/clinician-patient-communication-in-lung-cancer-care-44174https://curecurrent.com/trials/sacituzumab-tirumotecan-plus-anlotinib-in-previously-treated-es-sclc-44175https://curecurrent.com/trials/autologous-car-t-cells-targeting-the-gd2-antigen-for-lung-cancer-44176https://curecurrent.com/trials/photodynamic-therapy-to-amplify-the-response-to-immunotherapy-in-patients-with-non-small-cell-lung-cancer-with-pleural-d-44177https://curecurrent.com/trials/microwave-ablation-in-chinese-patients-with-lung-tumors-44178https://curecurrent.com/trials/oxford-pleural-embolisation-trial-44179https://curecurrent.com/trials/stereotactic-ablative-radiotherapy-sabr-for-the-treatment-of-patients-with-metastatic-cancer-id-comet-trial-44180https://curecurrent.com/trials/study-of-toripalimab-for-limited-stage-small-cell-lung-cancer-following-concurrent-chemoradiotherapy-44181https://curecurrent.com/trials/clinical-utility-of-liquid-biopsy-in-brigatinib-alk-patients-44182https://curecurrent.com/trials/adebrelimab-maintenance-therapy-for-ls-sclc-post-induction-chemo-adebrelimab-plus-crt-or-crt-alone-44183https://curecurrent.com/trials/effect-of-dexmedetomidine-on-lung-protection-in-elderly-patients-undergoing-laparoscopic-surgery-for-colorectal-cancer-44184https://curecurrent.com/trials/insomnia-in-patients-with-metastatic-lung-cancer-44185https://curecurrent.com/trials/adaptation-and-pilot-testing-of-a-lung-cancer-screening-decision-aid-for-patients-from-a-safety-net-healthcare-system-44186https://curecurrent.com/trials/investigation-of-the-effects-of-functional-inspiratory-muscle-training-in-patients-with-lung-cancer-44187https://curecurrent.com/trials/pilot-for-the-precision-exercise-regimen-for-cancer-care-percc-study-44188https://curecurrent.com/trials/combination-of-osimertinib-and-aspirin-to-treat-egfr-mutation-nsclc-patients-44189https://curecurrent.com/trials/coronary-computed-tomography-angiography-in-rheumatoid-arthritis-study-44190https://curecurrent.com/trials/immune-cells-role-in-lung-cancer-and-their-use-in-anticancer-immunotherapies-and-inflammatory-lung-disease-44191https://curecurrent.com/trials/lung-cancer-screening-in-population-who-had-never-smoked-44192https://curecurrent.com/trials/phase-iii-clinical-study-of-hb0025-combined-with-chemotherapy-versus-tislelizumab-combined-with-chemotherapy-as-first-li-44193https://curecurrent.com/trials/c-raven-a-virtual-tobacco-cessation-intervention-in-the-community-44194https://curecurrent.com/trials/bintrafusp-alfa-program-rollover-study-44195https://curecurrent.com/trials/a-study-of-local-ablative-therapy-lat-in-people-with-non-small-cell-lung-cancer-nsclc-44196https://curecurrent.com/trials/ebus-tbna-vs-transbronchial-mediastinal-cryobiopsy-for-adequacy-of-next-generation-sequencing-44197https://curecurrent.com/trials/a-study-evaluating-different-doses-of-bi-765049-when-given-alone-and-when-given-with-ezabenlimab-to-patients-with-advanc-44198https://curecurrent.com/trials/a-phase-ib-clinical-study-on-the-safety-and-efficacy-of-hc010-combined-with-chemotherapy-in-lung-cancer-44199https://curecurrent.com/trials/totally-robotic-versus-surgeon-assisted-robotic-lung-resection-for-early-stage-nsclc-44200https://curecurrent.com/trials/a-study-of-prt7732-an-oral-smarca2-degrader-in-patients-with-advanced-or-metastatic-solid-tumors-with-a-smarca4-mutation-44201https://curecurrent.com/trials/a-study-of-prt3789-in-combination-with-pembrolizumab-in-patients-with-advanced-or-metastatic-solid-tumors-with-a-smarca4-44202https://curecurrent.com/trials/near-infrared-fluorescence-guided-robotic-pulmonary-segmentectomy-for-early-stage-lung-cancer-44203https://curecurrent.com/trials/the-effect-of-kinisoquin-on-thromboembolic-events-in-patients-with-metastatic-or-locally-advanced-pancreatic-cancer-44204https://curecurrent.com/trials/bronchoscopic-microwave-ablation-of-lung-tissue-44205https://curecurrent.com/trials/3-dimensional-virtual-reality-modelling-with-intravascular-indocyanine-green-fluorescence-mapping-for-targeted-pulmonary-44206https://curecurrent.com/trials/synapse-3d-with-intravascular-indocyanine-green-44207https://curecurrent.com/trials/zimberelimab-and-domvanalimab-in-combination-with-chemotherapy-versus-pembrolizumab-with-chemotherapy-in-patients-with-u-44208https://curecurrent.com/trials/177lu-lu-akir001-first-in-human-study-44209https://curecurrent.com/trials/intrathecal-pemetrexed-for-leptomeningeal-metastasis-from-lung-adenocarcinoma-that-progressed-after-osimertinib-44210https://curecurrent.com/trials/a-study-to-compare-uliledlimab-combined-with-sintilimab-and-chemotherapy-versus-sintilimab-combined-with-chemotherapy-in-44211https://curecurrent.com/trials/a-study-to-compare-uliledlimab-combined-with-toripalimab-toripalimab-monotherapy-and-pembrolizumab-monotherapy-in-patien-44212https://curecurrent.com/trials/healthy-homes-study-44213https://curecurrent.com/trials/cryoablation-in-combination-or-not-with-pembrolizumab-and-pemetrexed-carboplatin-in-1st-line-treatment-for-patients-with-44214https://curecurrent.com/trials/the-primrose-trial-44215https://curecurrent.com/trials/the-thoracic-peri-operative-integrative-surgical-care-evaluation-trial-stage-iii-44216https://curecurrent.com/trials/clinical-study-of-shr-a1811-combined-with-pertuzumab-as-second-line-therapy-in-patients-with-her2-altered-advanced-nsclc-44217https://curecurrent.com/trials/assessing-and-addressing-follow-up-care-needs-that-will-facilitate-care-transitions-for-cancer-survivors-44218https://curecurrent.com/trials/impt-dose-escalation-for-nsclc-hydose-44219https://curecurrent.com/trials/a-study-of-tiragolumab-in-combination-with-atezolizumab-compared-with-placebo-in-combination-with-atezolizumab-in-patien-44220https://curecurrent.com/trials/emulation-of-the-flaura-nct02296125-trial-using-specialty-oncology-electronic-health-records-databases-44221https://curecurrent.com/trials/atovaquone-with-radical-chemoradiotherapy-in-locally-advanced-nsclc-44222https://curecurrent.com/trials/a-multi-modal-integrating-imaging-and-cell-free-dna-methylation-in-lung-cancer-early-detection-cme-lung-a-multi-center-o-44223https://curecurrent.com/trials/phase-i-trial-of-vs-6766-alone-and-in-combination-with-everolimus-44224https://curecurrent.com/trials/prospective-single-arm-phase-ii-clinical-study-of-irinotecan-hydrochloride-liposome-injection-combined-with-platinum-and-44225https://curecurrent.com/trials/ucdcc-272-il-2-radiotherapy-and-pembrolizumab-in-patients-refractory-to-checkpoint-blockade-44226https://curecurrent.com/trials/a-phase-1-study-of-tgi-5-as-monotherapy-and-in-combination-with-nivolumab-in-subjects-with-locally-advanced-metastatic-s-44227https://curecurrent.com/trials/assessing-an-oral-egfr-inhibitor-sunvozertinib-in-patients-who-have-advanced-non-small-cell-lung-cancer-with-egfr-or-her-44228https://curecurrent.com/trials/expanded-access-to-abbv-706-44229https://curecurrent.com/trials/subcutaneous-atezolizumab-for-the-treatment-of-non-small-cell-lung-cancer-44230https://curecurrent.com/trials/retrospective-multicenter-study-of-patient-level-t1ce-flair-mri-deep-learning-to-predict-egfr-alk-driver-status-in-nsclc-44231https://curecurrent.com/trials/markerless-image-guidance-using-intrafraction-kolovoltage-x-ray-imaging-for-lung-cancer-radiotherapy-44232https://curecurrent.com/trials/predicting-response-to-anti-pd-1-pd-l1-immunotherapy-by-plasma-extracellular-vesicle-analysis-44233https://curecurrent.com/trials/specimen-banking-from-patients-with-lung-cancer-44234https://curecurrent.com/trials/tobacco-cessation-at-fdny-44235https://curecurrent.com/trials/a-study-of-phn-010-in-patients-with-advanced-solid-tumors-44236https://curecurrent.com/trials/pembrolizumab-and-stereotactic-body-radiotherapy-in-metastatic-non-small-cell-lung-cancer-patients-44237https://curecurrent.com/trials/iruplinalkib-in-alk-positive-advanced-lung-adenocarcinoma-after-lorlatinib-44238https://curecurrent.com/trials/phase-1-2a-study-to-assess-the-safety-tolerability-pharmacokinetics-and-preliminary-efficacy-of-wef-001-as-monotherapy-i-44239https://curecurrent.com/trials/drug-concentration-monitoring-of-pembrolizumab-in-non-small-cell-lung-cancer-patients-44240https://curecurrent.com/trials/combination-of-atezolizumab-and-pirfenidone-in-second-line-and-beyond-nsclc-44241https://curecurrent.com/trials/perioperative-treatment-of-high-risk-resectable-cca-with-haic-plus-a-t-neobrave-cca-44242https://curecurrent.com/trials/effects-of-ciprofol-on-myocardial-injury-after-non-cardiac-surgery-in-video-assisted-thoracoscopic-surgery-44243https://curecurrent.com/trials/association-of-different-tidal-volumes-and-postoperative-pulmonary-complications-44244https://curecurrent.com/trials/an-phase-ib-ii-clinical-trial-of-tcc1727-combination-therapy-in-advanced-solid-tumors-44245https://curecurrent.com/trials/papaverine-and-stereotactic-body-radiotherapy-sbrt-for-non-small-cell-lung-cancer-nsclc-or-lung-metastases-44246https://curecurrent.com/trials/chemo-immunotherapy-plus-thoracic-radiotherapy-in-extensive-stage-small-cell-lung-cancer-44247https://curecurrent.com/trials/evaluation-of-different-sizes-of-left-sided-double-lumen-tubes-for-thoracic-surgery-in-a-tertiary-level-teaching-hospita-44248https://curecurrent.com/trials/the-prevention-of-bone-marrow-suppression-caused-by-chemotherapy-in-advanced-nsclc-with-trilaciclib-44249https://curecurrent.com/trials/smoking-cessation-before-bronchoscopy-or-ct-guided-puncture-44250https://curecurrent.com/trials/emitt-1-erap-mediated-immunopeptidome-targeting-trial-1-44251https://curecurrent.com/trials/a-prospective-single-arm-single-center-phase-ii-study-evaluating-the-efficacy-and-safety-of-chidamide-combined-with-pd-l-44252https://curecurrent.com/trials/phase-1-2-study-to-evaluate-th9619-in-the-treatment-of-advanced-solid-tumors-44253https://curecurrent.com/trials/study-of-antitumor-immune-response-after-ccrt-and-io-treatment-in-non-resectable-iii-stage-nsclc-patients-44254https://curecurrent.com/trials/immunochemotherapy-surgery-or-chemoradiation-and-durvalumab-for-stage-iiia-b-nsclc-44255https://curecurrent.com/trials/immune-profiling-of-stage-iii-non-small-cell-lung-cancer-patients-treated-with-concurrent-chemoradiation-and-adjuvant-du-44256https://curecurrent.com/trials/ezh2-inhibitor-tulmimetostat-and-pd-1-blockade-for-treatment-of-advanced-non-small-cell-lung-cancer-44257https://curecurrent.com/trials/a-study-to-evaluate-first-line-ipilimumab-nivolumab-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-44258https://curecurrent.com/trials/impact-of-circadian-rhythm-on-the-spread-of-circulating-tumor-cells-in-lung-cancer-patients-44259https://curecurrent.com/trials/targeted-telerehabilitation-following-curative-intent-therapy-of-lung-cancer-44260https://curecurrent.com/trials/research-on-early-screening-and-diagnosis-of-pulmonary-nodules-based-on-novel-non-invasive-technologies-44261https://curecurrent.com/trials/a-study-of-skb264-mk-2870-sac-tmt-for-the-treatment-of-participants-with-advanced-or-metastatic-non-small-cell-lung-canc-44262https://curecurrent.com/trials/18f-fapi-pet-in-lung-cancer-44263https://curecurrent.com/trials/costotransverse-foramen-block-versus-thoracic-paravertebral-block-in-thoracotomy-for-lung-cancer-44264https://curecurrent.com/trials/a-study-on-the-improvement-of-postoperative-symptoms-and-survival-benefits-of-modified-bufei-decoction-in-elderly-patien-44265https://curecurrent.com/trials/window-of-opportunity-trial-of-durvalumab-medi4736-to-identify-immune-dynamics-in-operable-non-small-cell-lung-cancer-ns-44266https://curecurrent.com/trials/optimizing-endobronchial-ultrasound-sampling-for-molecular-markers-for-nsclc-44267https://curecurrent.com/trials/large-granular-lymphocytes-in-mnsclc-treated-with-nivolumab-44268https://curecurrent.com/trials/a-study-of-ly2875358-in-participants-with-non-small-cell-lung-cancer-with-activating-epidermal-growth-factor-receptor-mu-44269https://curecurrent.com/trials/this-study-tests-the-new-medicine-bi-754111-alone-or-in-combination-with-another-new-substance-bi-754091-in-patients-wit-44270https://curecurrent.com/trials/furmonertinib-160mg-vs-80mg-chemotherapy-in-egfr-mutated-nsclc-with-brain-metastases-efficacy-and-safety-study-44271https://curecurrent.com/trials/breath-analysis-based-disease-biomarkers-44272https://curecurrent.com/trials/advancing-health-information-exchange-hie-during-inter-hospital-transfer-iht-to-improve-patient-outcomes-44273https://curecurrent.com/trials/a-phase-a-clinical-study-of-gen-725-in-combination-with-dositinib-44274https://curecurrent.com/trials/the-impact-of-surgical-technique-on-circulating-tumor-dna-in-stage-i-iii-non-small-cell-lung-cancer-44275https://curecurrent.com/trials/centralized-screening-unit-csu-at-montefiore-einstein-44276https://curecurrent.com/trials/first-in-human-study-of-sim0610-in-solid-tumors-44277https://curecurrent.com/trials/a-study-to-evaluate-nivolumab-in-combination-with-ipilimumab-versus-pemetrexed-with-cisplatin-or-carboplatin-for-unresec-44278https://curecurrent.com/trials/front-line-ibrutinib-without-corticosteroids-for-newly-diagnosed-chronic-graft-versus-host-disease-44279https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-tolerability-of-sctb14-as-first-line-therapy-in-non-small-cell-lung-cancer-44280https://curecurrent.com/trials/adjunctive-intravenous-ascorbic-acid-for-advanced-non-small-cell-lung-cancer-44281https://curecurrent.com/trials/expanded-access-to-nanopac-44282https://curecurrent.com/trials/first-in-human-study-of-qls5316-in-solid-tumors-44283https://curecurrent.com/trials/surufatinib-combined-with-chemo-versus-surufatinib-in-the-treatment-of-pulmonary-neuroendocrine-tumors-44284https://curecurrent.com/trials/elderly-cancer-patients-safety-and-quality-of-life-under-immunotherapies-44285https://curecurrent.com/trials/tiragolumab-and-atezolizumab-in-patients-with-non-squamous-non-small-cell-lung-cancer-nsclc-and-untreated-brain-metastas-44286https://curecurrent.com/trials/a-study-of-neoadjuvant-atezolizumab-plus-chemotherapy-versus-placebo-plus-chemotherapy-in-patients-with-resectable-stage-44287https://curecurrent.com/trials/safety-and-efficacy-evaluation-of-cryoablation-in-the-treatment-of-ground-glass-nodules-44288https://curecurrent.com/trials/prediction-of-postoperative-pulmonary-complications-in-thoracic-surgery-44289https://curecurrent.com/trials/intelligent-support-for-radiological-reporting-of-lung-neoplasms-44290https://curecurrent.com/trials/unhide-project-a-digital-health-platform-to-collect-lifestyle-data-for-brain-inflammation-research-44291https://curecurrent.com/trials/phase-iii-clinical-study-of-hb0025-combined-with-chemotherapy-versus-pembrolizumab-combined-with-chemotherapy-for-the-fi-44292https://curecurrent.com/trials/clinical-study-on-the-use-of-huaier-granules-for-the-treatment-of-proteinuria-related-to-bevacizumab-and-anlotinib-in-lu-44293https://curecurrent.com/trials/laryngopharyngeal-injury-after-endotracheal-intubation-under-general-anesthesia-44294https://curecurrent.com/trials/a-phase-l-clinical-study-to-evalute-the-safety-tolerability-pharmacokinetic-characteristics-and-preliminary-anti-tumor-e-44295https://curecurrent.com/trials/liquid-biopsy-based-pre-screening-to-streamline-ldct-lung-cancer-screening-in-high-risk-individuals-44296https://curecurrent.com/trials/exploration-of-treatment-strategies-after-concurrent-chemoradiotherapy-for-ls-sclc-guided-by-mrd-44297https://curecurrent.com/trials/evaluation-of-the-safety-and-effectiveness-of-the-tri-staple-technology-inthoracic-surgery-clinical-investigation-44298https://curecurrent.com/trials/firmonertinib-160-mg-in-patients-with-egfr-mutant-advanced-nsclc-demonstrating-sd-after-8-week-induction-with-firmonerti-44299https://curecurrent.com/trials/nivolumab-and-ipilimumab-in-treating-patients-with-hiv-associated-relapsed-or-refractory-classical-hodgkin-lymphoma-or-s-44300https://curecurrent.com/trials/a-study-to-compare-tissue-and-liquid-biopsies-in-people-with-different-types-of-cancer-44301https://curecurrent.com/trials/a-study-of-shr-a1811-in-first-line-treatment-of-patients-with-advanced-or-metastatic-non-small-cell-lung-cancer-with-her-44302https://curecurrent.com/trials/ceftolozane-tazobactam-for-directed-treatment-of-pseudomonas-aeruginosa-bacteremia-and-pneumonia-in-patients-with-hemato-44303https://curecurrent.com/trials/a-first-in-human-study-of-3h-10000-in-patients-with-unresectable-or-metastatic-solid-tumors-44304https://curecurrent.com/trials/a-study-of-gnc-077-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-and-other-solid-tumors-44305https://curecurrent.com/trials/amivantamab-lazertinib-and-bevacizumab-in-patients-with-egfr-mutant-advanced-non-small-cell-lung-cancer-with-progression-44306https://curecurrent.com/trials/phase-i-trial-of-carbonic-anhydrase-inhibition-in-combination-with-radiochemotherapy-or-radioimmunotherapy-in-small-cell-44307https://curecurrent.com/trials/unresectable-stage-iiia-iiib-non-small-cell-lung-cancer-nsclc-44308https://curecurrent.com/trials/radiotherapy-plus-anti-pd-1-versus-anti-pd-1-alone-in-yptanyn-m0-nsclc-44309https://curecurrent.com/trials/easyendotm-powered-in-thoracic-surgery-44310https://curecurrent.com/trials/study-on-the-effectiveness-and-safety-of-cle-combined-with-cryobiopsy-for-diagnosis-of-pulmonary-lesions-44311https://curecurrent.com/trials/folfox-haic-combined-with-donafenib-and-pucotenlimab-as-first-line-treatment-for-unresectable-intrahepatic-cholangiocarc-44312https://curecurrent.com/trials/chemotherapy-plus-pitavastatin-guided-by-patient-derived-tumor-like-cell-clusters-in-refractory-non-small-cell-lung-canc-44313https://curecurrent.com/trials/lung-05-investigating-chemotherapy-effectiveness-for-non-small-cell-lung-cancer-nsclc-metastatic-patients-44314https://curecurrent.com/trials/induction-lorlatinib-in-stage-iii-non-small-cell-lung-cancer-44315https://curecurrent.com/trials/pembrolizumab-imprime-pgg-for-metastatic-non-small-cell-lung-cancer-after-progression-on-first-line-therapy-big-ten-canc-44316https://curecurrent.com/trials/safety-and-efficacy-of-combining-apl-101-with-frontline-osimertinib-in-patients-with-egfr-mutated-metastatic-non-small-c-44317https://curecurrent.com/trials/a-phase-i-ii-study-of-nivolumab-ipilimumab-and-plinabulin-in-patients-with-recurrent-small-cell-lung-cancer-44318https://curecurrent.com/trials/functional-lung-avoidance-radiation-therapy-using-hyperpolarized-xenon-129-mri-44319https://curecurrent.com/trials/study-of-egf816-in-combination-with-selected-targeted-agents-in-egfr-mutant-nsclc-44320https://curecurrent.com/trials/thoracic-specimen-registry-44321https://curecurrent.com/trials/iparomlimab-and-tuvonralimab-injection-combined-with-chemotherapy-and-sequential-thoracic-radiotherapy-for-extensive-sta-44322https://curecurrent.com/trials/lidocaine-decreases-postoperative-lung-cancer-reoccurance-and-metatasis-risk-44323https://curecurrent.com/trials/a-study-of-roginolisib-ioa-244-in-combination-with-dostarlimab-with-or-without-docetaxel-in-metastatic-non-small-cell-lu-44324https://curecurrent.com/trials/assessing-e-cigarettes-for-tobacco-harm-reduction-in-the-context-of-lung-cancer-screening-44325https://curecurrent.com/trials/accelerated-hypofractionated-radiotherapy-in-the-treatment-of-malignant-pleural-mesothelioma-44326https://curecurrent.com/trials/lung-ultrasound-in-the-early-detection-of-postoperative-pulmonary-complications-after-esophagectomy-44327https://curecurrent.com/trials/sacituzumab-tirumotecan-plus-third-generation-tki-with-without-radiotherapy-for-egfr-mutant-nsclc-brain-metastases-44328https://curecurrent.com/trials/impact-of-different-lung-isolation-devices-on-pharyngolaryngeal-injuries-after-pulmonary-resection-44329https://curecurrent.com/trials/a-clinical-trial-to-determine-the-safety-and-efficacy-of-hope-biosciences-autologous-mesenchymal-stem-cell-therapy-for-t-44330https://curecurrent.com/trials/anlotinib-plus-penpulimab-as-second-line-treatment-for-patients-with-small-cell-lung-cancer-after-failure-of-platinum-ba-44331https://curecurrent.com/trials/sarcoidosis-immunotsuppressive-therapy-and-lymphoma-development-44332https://curecurrent.com/trials/safety-trial-of-antimicrobial-therapy-and-precision-radiation-therapy-in-patients-with-oligoprogressive-non-small-cell-l-44333https://curecurrent.com/trials/institutional-registry-of-rare-diseases-44334https://curecurrent.com/trials/quilt-3-055-a-study-of-combination-immunotherapies-in-patients-who-have-previously-received-treatment-with-immune-checkp-44335https://curecurrent.com/trials/radiation-during-osimertinib-treatment-a-safety-and-efficacy-cohort-study-44336https://curecurrent.com/trials/a-study-evaluating-neoadjuvant-chemotherapy-concurrent-chemoradiotherapy-combined-with-dual-immune-checkpoint-blockade-i-44337https://curecurrent.com/trials/mobilization-before-and-after-video-assisted-thoracoscopic-surgery-lobectomy-segmentectomy-44338https://curecurrent.com/trials/glecirasib-combined-with-ivonescimab-for-first-line-treatment-of-kras-g12c-mutated-nsclc-44339https://curecurrent.com/trials/functional-lung-avoidance-planning-guided-by-lung-perfusion-pet-ct-versus-anatomical-planning-for-lung-stereotactic-body-44340https://curecurrent.com/trials/induction-chemo-immunotherapy-in-resectable-epithelioid-and-biphasic-pleural-mesothelioma-chimera-study-44341https://curecurrent.com/trials/this-study-tests-how-bi-754111-is-distributed-in-patients-with-advanced-non-small-cell-lung-cancer-or-patients-with-head-44342https://curecurrent.com/trials/a-prospective-multicenter-study-of-the-association-between-tcm-syndromes-and-egfr-tki-efficacy-in-lung-cancer-patients-44343https://curecurrent.com/trials/jab-21822-activity-in-adult-patients-with-advanced-solid-tumors-harboring-kras-g12c-mutation-44344https://curecurrent.com/trials/prospective-evaluation-of-68ga-fapi-pet-in-biliary-cancers-44345https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-serplulimab-in-combination-with-chemotherapy-and-concurrent-radiotherapy-44346https://curecurrent.com/trials/retifanlimab-and-ruxolitinib-in-solid-malignancies-44347https://curecurrent.com/trials/a-study-of-xl184-cabozantinib-with-or-without-erlotinib-in-subjects-with-non-small-cell-lung-cancer-nsclc-44348https://curecurrent.com/trials/impact-of-pretreatment-emotional-distress-on-survival-and-the-predictive-role-of-peripheral-biomarkers-in-immunotherapy-44349https://curecurrent.com/trials/inhaled-mrna-tumor-associated-antigen-dry-powder-vaccine-in-advanced-lung-cancer-and-lung-metastasis-of-solid-tumors-44350https://curecurrent.com/trials/cough-capture-as-a-portal-into-the-lung-44351https://curecurrent.com/trials/a-study-of-dabrafenib-in-combination-with-trametinib-in-chinese-patients-with-braf-v600e-mutant-metastatic-nsclc-44352https://curecurrent.com/trials/study-of-decoy20-with-or-without-tislelizumab-in-patients-with-advanced-solid-tumors-44353https://curecurrent.com/trials/a-study-to-evaluate-the-safety-pharmacokinetics-and-efficacy-of-tj101-in-patients-with-advanced-metastatic-solid-tumors-44354https://curecurrent.com/trials/a-phase-iii-study-with-thio-cemiplimab-vs-chemotherapy-as-3rd-line-treatment-in-advanced-metastatic-nsclc-44355https://curecurrent.com/trials/phase-1-2-study-of-avutometinib-vs-6766-sotorasib-with-or-without-defactinib-in-kras-g12c-nsclc-patients-44356https://curecurrent.com/trials/association-of-bal-fluid-t-cell-immune-activity-with-tumor-pd-l1-expression-and-its-prognostic-value-a-prospective-obser-44357https://curecurrent.com/trials/impact-of-a-hypnotic-recording-on-artifacts-in-4d-ct-in-the-context-of-stereotactic-body-radiation-therapy-for-lung-canc-44358https://curecurrent.com/trials/125i-seed-implantation-plus-systemic-therapy-for-oligoprogressive-nsclc-or-colorectal-cancer-44359https://curecurrent.com/trials/lung-cancer-surgery-in-sarcopenia-patients-with-old-age-44360https://curecurrent.com/trials/a-study-of-risk-factors-for-the-covid-19-virus-infection-44361https://curecurrent.com/trials/phase-ii-single-arm-study-of-azd9291-to-treat-nsclc-patients-in-asia-pacific-44362https://curecurrent.com/trials/impact-of-covid-19-pandemic-waves-on-colorectal-cancer-stage-migration-and-diagnostic-delays-44363https://curecurrent.com/trials/ql1706-combined-with-chemotherapy-in-the-treatment-of-immune-mediated-nsclc-44364https://curecurrent.com/trials/single-cell-sequencing-analysis-of-radiation-pneumonitis-signals-in-patients-treated-for-cancer-with-radiotherapy-44365https://curecurrent.com/trials/talent-study-phase-ii-trial-of-adjuvant-l-til-plus-tislelizumab-in-resectable-nsclc-without-pcr-after-neoadjuvant-chemoi-44366https://curecurrent.com/trials/wast-cell-docetaxel-combination-therapy-in-pd-1-inhibitor-resistant-advanced-nsclc-44367https://curecurrent.com/trials/lotus-cc-an-observational-research-study-to-uncover-subtypes-of-cancer-cachexia-44368https://curecurrent.com/trials/circulating-tumor-dna-guided-treatment-monitoring-in-advanced-lung-cancer-44369https://curecurrent.com/trials/a-study-of-abbv-927-and-abbv-181-an-immunotherapy-in-participants-with-advanced-solid-tumors-44370https://curecurrent.com/trials/efficacy-and-safety-of-tt-00420-tinengotinib-tablets-versus-chemotherapy-in-patients-with-advanced-intrahepatic-cholangi-44371https://curecurrent.com/trials/short-term-effects-of-osteopathic-manipulations-on-heart-rate-variability-in-lung-cancer-patients-a-randomized-pilot-stu-44372https://curecurrent.com/trials/study-of-immunotherapy-sasanlimab-in-combination-with-targeted-therapies-in-people-with-advanced-non-small-cell-lung-can-44373https://curecurrent.com/trials/patient-derived-tumor-like-cell-cluster-model-based-precision-treatment-strategy-on-non-small-cell-lung-cancer-44374https://curecurrent.com/trials/antrodia-cinnamomea-extract-effects-on-lung-cancer-patients-quality-of-life-during-chemotherapy-44375https://curecurrent.com/trials/molecular-phenotyping-of-primitive-lung-cancer-and-metastatic-site-44376https://curecurrent.com/trials/adoptive-cell-therapy-using-cancer-specific-cd8-tumor-infiltrating-lymphocytes-in-adult-patients-with-solid-tumors-44377https://curecurrent.com/trials/breathlessness-patterns-in-patients-with-cancer-copd-and-heart-failure-an-fmri-feasibility-study-44378https://curecurrent.com/trials/a-pilot-phase-ii-study-of-maintenance-cabozantinib-plus-pembrolizumab-for-patients-with-metastatic-squamous-non-small-ce-44379https://curecurrent.com/trials/study-of-nivolumab-ipilimumab-and-cfdna-in-lung-cancer-44380https://curecurrent.com/trials/tele-navigation-of-lung-cancer-screening-tele-navi-lcs-44381https://curecurrent.com/trials/urolithin-a-in-patients-with-previously-untreated-solid-tumors-receiving-immune-checkpoint-inhibitors-44382https://curecurrent.com/trials/taletrectinib-phase-2-global-study-in-ros1-positive-nsclc-44383https://curecurrent.com/trials/osimertinib-combined-with-savolitinib-in-the-treatment-of-nsclc-with-low-copy-number-met-amplification-44384https://curecurrent.com/trials/a-study-describing-real-world-effectiveness-of-nivolumab-chemotherapy-in-neoadjuvant-nsclc-44385https://curecurrent.com/trials/tocilizumab-and-atezolizumab-in-adults-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-refractory-to-1st-44386https://curecurrent.com/trials/high-dose-dexamethasone-to-reduce-postoperative-pain-after-video-assisted-thoracoscopic-surgery-lobectomy-segmentectomy-44387https://curecurrent.com/trials/neoadjuvant-sacituzumab-tirumotecan-and-limertinib-for-potentially-resectable-stage-egfr-mutant-non-small-cell-lung-canc-44388https://curecurrent.com/trials/risk-factors-for-neuroendocrine-neoplasms-44389https://curecurrent.com/trials/postoperative-radiotherapy-for-postoperative-n2-metastases-of-nsclc-in-the-immunotherapy-era-phase-ii-44390https://curecurrent.com/trials/a-neoadjuvant-study-of-nivolumab-plus-ipilimumab-or-nivolumab-plus-chemotherapy-versus-chemotherapy-alone-in-early-stage-44391https://curecurrent.com/trials/nk-cell-therapy-combined-with-pd-1-antibody-and-platinum-based-chemotherapy-as-neoadjuvant-therapy-in-resectable-nsclc-44392https://curecurrent.com/trials/combination-study-of-rmc-4630-and-sotorasib-for-nsclc-subjects-with-krasg12c-mutation-after-failure-of-prior-standard-th-44393https://curecurrent.com/trials/a-phase-ii-iii-clinical-study-to-evaluate-hlx07-in-combination-with-serplulimab-and-chemotherapy-versus-placebo-in-combi-44394https://curecurrent.com/trials/spatiotemporal-associations-between-the-covid-19-pandemic-and-cancer-diagnoses-in-bavaria-44395https://curecurrent.com/trials/zg006-and-zg005-in-participants-with-small-cell-lung-cancer-or-neuroendocrine-carcinoma-44396https://curecurrent.com/trials/a-study-of-gimistotug-bgb-a445-in-combination-with-other-investigational-agents-in-participants-with-non-small-cell-lung-44397https://curecurrent.com/trials/study-comparing-tarlatamab-with-standard-of-care-chemotherapy-in-relapsed-small-cell-lung-cancer-44398https://curecurrent.com/trials/prevalence-of-alpha-1-antitrypsin-deficiency-in-non-cirrhotic-liver-cancer-44399https://curecurrent.com/trials/adaptive-adjuvant-sintilimab-therapy-guided-by-mrd-adapt-lung-44400https://curecurrent.com/trials/study-comparing-zg006-with-investigator-selected-chemotherapy-in-participants-with-relapsed-small-cell-lung-cancer-44401https://curecurrent.com/trials/study-of-zg005-combined-with-gecacitinib-in-patients-with-advanced-non-small-cell-lung-cancer-44402https://curecurrent.com/trials/study-of-zggs18-in-combination-with-zg005-in-patients-with-advanced-solid-tumors-44403https://curecurrent.com/trials/cxcr4-pet-ct-for-predicting-outcome-in-limited-stage-small-cell-lung-cancer-44404https://curecurrent.com/trials/study-of-zg006-in-participants-with-small-cell-lung-cancer-or-neuroendocrine-carcinoma-44405https://curecurrent.com/trials/locally-advanced-nsclc-treated-with-radiochemotherapy-phase-2-study-on-the-value-of-a-stereotactic-boost-44406https://curecurrent.com/trials/c-til051-in-non-small-cell-lung-cancer-44407https://curecurrent.com/trials/using-xe-mri-to-guide-radiation-therapy-for-lung-cancer-44408https://curecurrent.com/trials/parametric-imaging-in-positron-emission-tomography-for-patient-with-lung-cancer-44409https://curecurrent.com/trials/low-dose-radiation-sbrt-tislelizumab-plus-platinum-based-chemotherapy-in-stage-a-b-non-small-cell-lung-cancer-44410https://curecurrent.com/trials/dynamics-of-18-fdg-uptake-in-stage-iii-iv-non-small-cell-lung-cancer-during-first-line-pembrolizumab-treatment-44411https://curecurrent.com/trials/study-of-interest-of-personalized-radiotherapy-dose-redistribution-in-patients-with-stage-iii-nsclc-44412https://curecurrent.com/trials/adjuvant-treatment-with-cisplatin-based-chemotherapy-plus-concomitant-atezolizumab-in-patients-with-stage-i-tumors-4cm-i-44413https://curecurrent.com/trials/the-ccaned-cipher-study-early-cancer-detection-and-treatment-response-monitoring-using-ai-based-platelet-and-immune-cell-44414https://curecurrent.com/trials/sleeve-lobectomy-following-neoadjuvant-therapy-in-nsclc-44415https://curecurrent.com/trials/the-her-project-hrd-in-egfr-mutated-nsclc-44416https://curecurrent.com/trials/phase-ii-study-of-durvalumab-doxorubicin-and-ifosfamide-in-pulmonary-sarcomatoid-carcinoma-44417https://curecurrent.com/trials/a-phase-ii-clinical-trial-of-dzd9008-in-combination-with-azd4205-in-standard-treatment-failed-nsclc-patients-with-egfr-m-44418https://curecurrent.com/trials/durvalumab-as-consolidation-therapy-in-patients-with-ls-sclc-following-scrt-44419https://curecurrent.com/trials/description-of-neurocognitive-and-psychiatric-disorders-associated-with-targeted-therapies-used-in-the-treatment-of-lung-44420https://curecurrent.com/trials/immunization-with-imm-101-vs-observation-for-prevention-of-respiratory-and-severe-covid-19-related-infections-in-cancer-44421https://curecurrent.com/trials/bolstering-outcomes-after-induction-with-osimertinib-plus-chemotherapy-through-optimized-site-directed-primary-tumor-the-44422https://curecurrent.com/trials/patients-and-health-staff-of-cancer-centres-during-the-covid-19-pandemic-44423https://curecurrent.com/trials/haic-plus-systemic-chemotherapy-lenvatinib-and-toripalimab-in-advanced-icc-44424https://curecurrent.com/trials/adebrelimab-combine-with-etoposide-capsules-in-es-sclc-maintenance-therapy-44425https://curecurrent.com/trials/ladarixin-with-sotorasib-in-advanced-nsclc-44426https://curecurrent.com/trials/validation-of-molecular-diagnostic-assays-to-detect-cancer-biomarkers-in-blood-and-primary-tumor-in-hnscc-nsclc-melanoma-44427https://curecurrent.com/trials/head-to-head-evaluation-of-the-cancer-ontology-supervised-multimodal-orchestration-cosmo-ai-system-versus-pathologist-on-44428https://curecurrent.com/trials/a-phase-ii-study-of-anlotinib-and-platinum-based-chemotherapy-in-patients-with-smarca4-deficient-locally-advanced-or-met-44429https://curecurrent.com/trials/navigate-improving-survival-and-quality-of-life-in-vulnerable-lung-cancer-patients-44430https://curecurrent.com/trials/real-world-study-of-toripalimab-in-extensive-stage-small-cell-lung-cancer-44431https://curecurrent.com/trials/smartest-trial-44432https://curecurrent.com/trials/epic-extracorporeal-photopheresis-ecp-for-immune-related-colitis-44433https://curecurrent.com/trials/reduced-dose-apixaban-and-rivaroxaban-versus-low-molecular-weight-heparin-in-patients-with-hematologic-malignancies-44434https://curecurrent.com/trials/golidocitinib-for-refractory-immune-related-hematologic-toxicities-of-advanced-lung-cancer-44435https://curecurrent.com/trials/furmonertinib-combined-with-intrathecal-chemotherapy-and-stereotactic-radiotherapy-srt-for-egfr-mutated-nsclc-patients-w-44436https://curecurrent.com/trials/molecular-analysis-of-thoracic-malignancies-44437https://curecurrent.com/trials/role-of-extracellular-vesicles-as-biomarkers-of-pulmonary-involvement-in-patients-with-lymphangioleiomyomatosis-and-tube-44438https://curecurrent.com/trials/ambispective-registry-of-patients-affected-by-lung-cancer-44439https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-monotherapy-versus-sacituzumab-govitecan-in-combination-with-pembrolizumab-for-participan-44440https://curecurrent.com/trials/differentiation-of-benign-and-malignant-pulmonary-nodules-by-volatile-organic-compounds-in-human-exhaled-breath-44441https://curecurrent.com/trials/sunvozertinib-treatment-in-untreated-advanced-nsclc-with-egfr-uncommon-mutations-44442https://curecurrent.com/trials/multilevel-interventions-to-increase-adherence-to-lung-cancer-screening-44443https://curecurrent.com/trials/impact-of-fat-free-mass-in-the-carboplatin-calculated-dose-and-chemotherapeutic-toxicity-in-patients-with-advanced-nsclc-44444https://curecurrent.com/trials/a-study-of-hbi-8000-tucidinostat-with-pembrolizumab-in-non-small-cell-lung-cancer-44445https://curecurrent.com/trials/exploratory-trial-of-navigational-bronchoscopy-guided-cryoablation-in-lung-cancer-treatment-44446https://curecurrent.com/trials/effect-of-technology-assisted-preoperative-home-exercise-on-postoperative-handgrip-strength-muscle-endurance-and-psychol-44447https://curecurrent.com/trials/expanded-access-program-of-taletrectinib-in-patients-with-advanced-or-metastatic-ros1-positive-nsclc-44448https://curecurrent.com/trials/akershus-cardiac-examination-ace-5-study-44449https://curecurrent.com/trials/lung-cancer-screening-program-in-mexico-44450https://curecurrent.com/trials/evaluation-of-lymph-node-analysis-using-one-step-nucleic-acid-amplification-osna-in-patients-with-lung-cancer-who-underw-44451https://curecurrent.com/trials/oncolytic-adenovirus-tilt-123-with-pembrolizumab-as-treatment-for-refractory-non-small-cell-lung-cancer-44452https://curecurrent.com/trials/study-of-cvm-1118-for-patients-with-advanced-neuroendocrine-tumors-44453https://curecurrent.com/trials/safety-and-efficiency-of-the-years-algorithm-versus-computed-tomography-pulmonary-angiography-alone-for-suspected-pulmon-44454https://curecurrent.com/trials/prediction-of-response-to-treatment-with-immunotherapy-chemotherapy-in-non-small-cell-lung-cancer-44455https://curecurrent.com/trials/scale-of-therapeutic-adherence-to-respiratory-rahabilitation-for-lung-cancer-44456https://curecurrent.com/trials/study-of-dacomitinib-and-osimertinib-for-patients-with-advanced-egfr-mutant-lung-cancer-44457https://curecurrent.com/trials/a-trial-of-shr-a2102-with-adebrelimab-with-or-without-other-antitumor-therapy-in-advanced-or-metastatic-non-small-cell-l-44458https://curecurrent.com/trials/study-of-the-efficacy-and-safety-of-the-bintrafusp-alfa-in-previously-treated-advanced-malignant-pleural-mesothelioma-44459https://curecurrent.com/trials/detection-of-plasma-dna-in-non-small-cell-and-small-cell-lung-cancer-patients-44460https://curecurrent.com/trials/study-of-tyk-01054-capsules-in-patients-with-advanced-solid-tumors-44461https://curecurrent.com/trials/testing-the-engaged-approach-to-lung-cancer-screening-44462https://curecurrent.com/trials/study-of-atezolizumab-in-combination-with-cabozantinib-versus-docetaxel-in-patients-with-metastatic-non-small-cell-lung-44463https://curecurrent.com/trials/benefit-evaluation-of-foot-reflexology-in-oncology-44464https://curecurrent.com/trials/garsorasib-in-kras-g12c-mutant-locally-advanced-and-metastatic-nsclc-44465https://curecurrent.com/trials/crizotinib-in-treating-patients-with-stage-ib-iiia-non-small-cell-lung-cancer-that-has-been-removed-by-surgery-and-alk-f-44466https://curecurrent.com/trials/a-platform-study-of-novel-agents-in-combination-with-radiotherapy-in-nsclc-44467https://curecurrent.com/trials/evaluation-of-ultra-portable-ultrasound-in-general-practice-44468https://curecurrent.com/trials/digitally-enhanced-smoking-cessation-for-high-risk-smokers-44469https://curecurrent.com/trials/phase-3-study-of-pyrotinib-versus-docetaxel-in-patients-with-advanced-non-squamous-nsclc-harboring-a-her2-exon-20-mutati-44470https://curecurrent.com/trials/clinical-trial-evaluating-the-activity-of-zanidatamab-for-the-treatment-of-patients-with-solid-tumors-with-an-alteration-44471https://curecurrent.com/trials/tumors-and-respiratory-system-diseases-due-to-air-pollution-new-biomarkers-of-exposure-and-effects-44472https://curecurrent.com/trials/tubeless-vats-for-lung-cancer-surgery-44473https://curecurrent.com/trials/targeted-abdominal-ct-in-conjunction-with-lung-cancer-screening-44474https://curecurrent.com/trials/using-ctdna-to-determine-therapies-for-lung-cancer-44475https://curecurrent.com/trials/toripalimab-combined-with-sbrt-for-nsclc-44476https://curecurrent.com/trials/rasopathy-biorepository-44477https://curecurrent.com/trials/a-phase-ii-study-of-ssgj-706-monotherapy-and-combination-therapy-in-advanced-non-small-cell-lung-cancer-nsclc-patients-44478https://curecurrent.com/trials/accelerating-lung-cancer-diagnosis-through-liquid-biopsy-44479https://curecurrent.com/trials/testing-experimental-anti-cancer-drug-slc-391-with-an-approved-immunotherapy-drug-pembrolizumab-for-advanced-lung-cancer-44480https://curecurrent.com/trials/a-trial-of-hrs-4508-in-subjects-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-44481https://curecurrent.com/trials/phase-ii-study-of-radiotherapy-followed-by-durvalumab-and-ceralasertib-in-stage-iii-nsclc-patients-with-thoracic-relapse-44482https://curecurrent.com/trials/jmt106-injection-in-the-treatment-of-advanced-solid-tumors-44483https://curecurrent.com/trials/a-study-of-amivantamab-and-lazertinib-in-people-with-non-small-cell-lung-cancer-nsclc-44484https://curecurrent.com/trials/transarterial-chemoperfusion-cisplatin-methotrexate-gemcitabine-for-unresectable-pleural-mesothelioma-44485https://curecurrent.com/trials/study-comparing-tarlatamab-and-durvalumab-versus-durvalumab-alone-in-first-line-extensive-stage-small-cell-lung-cancer-e-44486https://curecurrent.com/trials/prediction-of-targeted-therapy-efficacy-in-egfr-mutant-lung-cancer-patients-using-ai-based-multimodal-data-44487https://curecurrent.com/trials/a-prospective-single-arm-exploratory-study-of-ibi363-in-es-sclc-patients-after-immunotherapy-progression-44488https://curecurrent.com/trials/a-study-to-evaluate-the-impact-of-liquid-biopsy-in-participants-with-a-clinical-diagnosis-of-advanced-cancer-44489https://curecurrent.com/trials/hc010-in-first-line-pd-l1-positive-advanced-nsclc-patients-44490https://curecurrent.com/trials/study-of-bms-986315-alone-and-in-combination-with-nivolumab-or-cetuximab-in-participants-with-advanced-solid-tumors-44491https://curecurrent.com/trials/rose-for-improved-molecular-marker-testing-via-ebus-44492https://curecurrent.com/trials/full-field-optical-coherence-tomography-ffoct-for-evaluation-of-bronchoscopic-small-biopsy-specimens-44493https://curecurrent.com/trials/phase-1-study-evaluating-the-safety-and-pk-of-adu-1805-in-advanced-solid-tumors-44494https://curecurrent.com/trials/exploring-the-effects-of-transcutaneous-electrical-acupoint-stimulation-therapy-on-patients-after-video-assisted-thoraco-44495https://curecurrent.com/trials/paccelio-fdg-pet-based-small-volume-accelerated-immuno-chemoradiotherapy-in-locally-advanced-nsclc-44496https://curecurrent.com/trials/phase-ii-trial-low-dose-radiation-sbrt-sintilimab-chemotherapy-vs-sintilimab-chemotherapy-in-locally-advanced-or-metasta-44497https://curecurrent.com/trials/a-study-of-nivolumab-and-ipilimumab-combined-with-chemotherapy-compared-to-chemotherapy-alone-in-first-line-nsclc-44498https://curecurrent.com/trials/effects-of-genomic-profiles-on-thromboembolic-risk-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-c-44499https://curecurrent.com/trials/acupuncture-for-enhancing-immunotherapy-in-advanced-nsclc-a-pilot-study-44500https://curecurrent.com/trials/study-of-plk1-inhibitor-onvansertib-in-relapsed-small-cell-lung-cancer-44501https://curecurrent.com/trials/tepotinib-vs-standard-treatment-in-patients-with-advanced-met-exon-14-mutated-non-small-cell-lung-cancer-previously-trea-44502https://curecurrent.com/trials/tarlox-and-sotorasib-in-patients-with-kras-g12c-mutations-44503https://curecurrent.com/trials/a-trial-of-integrating-sbrt-with-targeted-therapy-in-stage-iv-oncogene-driven-nsclc-44504https://curecurrent.com/trials/clinical-study-of-antibody-drug-conjugate-mytx-011-in-subjects-with-non-small-cell-lung-cancer-44505https://curecurrent.com/trials/a-study-to-evaluate-ans014004-in-combination-with-egfr-tki-in-non-small-cell-lung-cancer-44506https://curecurrent.com/trials/stereotactic-body-radiotherapy-with-sequential-iparomlimab-and-tuvonralimab-ql1706-chemotherapy-as-neoadjuvant-therapy-i-44507https://curecurrent.com/trials/clinical-study-of-the-therapeutic-effectiveness-of-in-silico-designed-machine-learning-inspired-and-quantum-molecularly-44508https://curecurrent.com/trials/durvalumab-and-chemotherapy-induction-followed-by-durvalumab-and-radiotherapy-in-large-volume-stage-iii-nsclc-44509https://curecurrent.com/trials/pembrolizumab-paclitaxel-carboplatin-and-radiation-therapy-in-treating-patients-with-stage-ii-iiib-non-small-cell-lung-c-44510https://curecurrent.com/trials/a-phase-ii-clinical-study-to-evaluate-the-safety-efficacy-pharmacokinetics-pharmacodynamics-of-jskn033-in-patients-with-44511https://curecurrent.com/trials/a-phase-3-study-of-sunvozertinib-versus-placebo-as-adjuvant-therapy-in-patients-with-early-stage-non-small-cell-lung-can-44512https://curecurrent.com/trials/a-study-of-sgn-b6a-in-chinese-participants-with-advanced-solid-tumors-44513https://curecurrent.com/trials/lamivudine-in-combination-with-chemoimmunotherapy-for-the-treatment-of-extensive-stage-small-cell-lung-cancer-44514https://curecurrent.com/trials/cancer-of-the-lung-and-senescence-prospective-cohort-1-44515https://curecurrent.com/trials/a-study-of-shr-a1811-combined-with-adebelimumab-as-neoadjuvant-therapy-for-resectable-her2-altered-non-small-cell-lung-c-44516https://curecurrent.com/trials/a-trial-of-hrs-4508-combined-with-other-antitumor-therapies-in-subjects-with-locally-advanced-or-metastatic-non-small-ce-44517https://curecurrent.com/trials/evaluation-of-ai-assisted-ldct-screening-in-lung-cancer-44518https://curecurrent.com/trials/nivolumab-for-the-reversal-of-squamous-dysplasia-in-high-risk-current-and-former-smokers-44519https://curecurrent.com/trials/vmd-928-monotherapy-and-in-combination-with-pembrolizumab-to-treat-trka-overexpression-driven-solid-tumors-or-lymphoma-44520https://curecurrent.com/trials/efficacy-and-safety-study-of-stereotactic-body-radiotherapy-sbrt-with-or-without-pembrolizumab-mk-3475-in-adults-with-un-44521https://curecurrent.com/trials/a-study-to-evaluate-participant-and-healthcare-professional-reported-preference-for-subcutaneous-atezolizumab-compared-w-44522https://curecurrent.com/trials/adi-peg-20-in-combination-with-gemcitabine-and-docetaxel-for-the-treatment-of-soft-tissue-sarcoma-osteosarcoma-ewing-s-s-44523https://curecurrent.com/trials/the-percutaneous-interventional-surgery-control-system-for-pulmonary-nodule-biopsy-44524https://curecurrent.com/trials/activity-safety-and-pharmacokinetics-in-pediatric-subjects-with-moderate-and-severe-chronic-graft-vs-host-disease-after-44525https://curecurrent.com/trials/neoadjuvant-sunvozertinib-in-stage-ii-iiib-non-small-cell-lung-cancer-harboring-egfr-exon-20-insertion-mutation-44526https://curecurrent.com/trials/centralized-lung-cancer-screening-engagement-in-at-risk-populations-44527https://curecurrent.com/trials/hyperprogression-in-pd-l1-50-nsclc-a-biomarker-guided-phase-2-trial-44528https://curecurrent.com/trials/impact-of-circadian-rhythm-on-immunotherapy-44529https://curecurrent.com/trials/an-autologous-nk-cik-cell-product-pb101-in-combination-with-egfr-tki-for-treating-lung-cancer-44530https://curecurrent.com/trials/adh1b-and-aldh-gene-variants-and-lung-cancer-risk-44531https://curecurrent.com/trials/a-phase-iii-study-to-investigate-efficacy-and-safety-of-hlx10-chemotherapy-in-patients-with-es-sclc-44532https://curecurrent.com/trials/telescope-telehealth-shared-decision-making-coaching-44533https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-pharmacokinetic-properties-of-9mw3811-in-healthy-subjects-44534https://curecurrent.com/trials/a-phase-2-randomized-controlled-trial-of-ql1706-plus-chemotherapy-and-quad-shot-for-driver-gene-negative-advanced-non-sm-44535https://curecurrent.com/trials/evaluation-of-efficacy-of-minimally-invasive-local-therapy-for-lung-tumors-and-its-impact-on-breathing-function-44536https://curecurrent.com/trials/mage-a10-t-for-advanced-nsclc-44537https://curecurrent.com/trials/this-study-is-comparing-morning-vs-random-scheduling-of-standard-of-care-pembrolizumab-checkpoint-inhibitor-immunotherap-44538https://curecurrent.com/trials/community-based-engagement-to-improve-lung-cancer-screening-and-outcomes-the-our-lungs-our-health-study-44539https://curecurrent.com/trials/clinico-biological-data-collection-study-of-metastatic-lung-cancer-44540https://curecurrent.com/trials/lk101-combined-with-pd-1-or-pd-l1-monoclonal-antibody-in-the-treatment-of-lung-cancer-44541https://curecurrent.com/trials/a-study-of-sys6010-combined-with-osimertinib-versus-osimertinib-alone-as-neoadjuvant-therapy-for-patients-with-egfr-muta-44542https://curecurrent.com/trials/cancer-therapy-related-cardiac-dysfunction-associated-with-egfr-tkis-in-advanced-egfr-mutant-non-small-cell-lung-cancer-44543https://curecurrent.com/trials/boxr1030-t-cells-in-subjects-with-advanced-gpc3-positive-solid-tumors-44544https://curecurrent.com/trials/post-line-treatment-with-teniposide-for-c-myc-driven-extensive-stage-small-cell-lung-cancer-44545https://curecurrent.com/trials/pirfenidone-combined-with-standard-first-line-chemotherapy-in-advanced-stage-lung-nsclc-44546https://curecurrent.com/trials/a-study-to-investigate-atezolizumab-subcutaneous-in-patients-with-previously-treated-locally-advanced-or-metastatic-non-44547https://curecurrent.com/trials/testing-the-use-of-targeted-treatment-amg-510-for-kras-g12c-mutated-advanced-non-squamous-non-small-cell-lung-cancer-a-l-44548https://curecurrent.com/trials/atezolizumab-plus-bevacizumab-in-first-line-nsclc-patients-44549https://curecurrent.com/trials/investigation-of-mp-pollution-in-the-human-respiratory-system-and-its-relationship-to-lung-cancer-44550https://curecurrent.com/trials/pembrolizumab-in-combination-with-chemotherapy-and-image-guided-surgery-for-malignant-pleural-mesothelioma-mpm-44551https://curecurrent.com/trials/neoadjuvant-chemo-immunotherapy-for-stage-iii-pd-l1-positive-non-small-cell-lung-cancer-nsclc-44552https://curecurrent.com/trials/early-assessment-of-response-to-treatment-of-metastatic-lung-tumors-based-on-circulating-tumor-dna-44553https://curecurrent.com/trials/predictive-value-of-exosomes-in-pleural-effusion-for-advanced-lung-cancer-44554https://curecurrent.com/trials/evaluate-the-safety-tolerability-biodistribution-characteristics-and-preliminary-efficacy-of-biottt001-44555https://curecurrent.com/trials/bms-986156-ipilimumab-and-nivolumab-with-or-without-stereotactic-body-radiation-therapy-in-treating-patients-with-advanc-44556https://curecurrent.com/trials/study-of-tbi-1301-ny-eso-1-specific-tcr-gene-transduced-autologous-t-lymphocytes-in-patients-with-solid-tumors-44557https://curecurrent.com/trials/screening-of-cancer-patients-to-assess-impact-of-covid-19-44558https://curecurrent.com/trials/non-invasive-ventilation-preoperative-lung-resection-surgery-44559https://curecurrent.com/trials/the-efficacy-and-safety-of-arni-on-the-outcome-of-advanced-lung-cancer-with-concurrent-hypertension-44560https://curecurrent.com/trials/study-of-gv20-0251-in-participants-with-solid-tumor-malignancies-44561https://curecurrent.com/trials/identification-of-palliative-care-needs-and-prognostic-factors-of-survival-in-tailoring-appropriate-interventions-in-adv-44562https://curecurrent.com/trials/influence-of-a-psychological-intensive-support-program-for-lung-cancer-patients-on-post-operative-outcomes-44563https://curecurrent.com/trials/js004-combined-with-toripalimab-and-with-standard-chemotherapy-treat-patients-with-advanced-lung-cancer-44564https://curecurrent.com/trials/phase-ii-clinical-study-of-pyrotinib-in-first-line-treatment-of-primary-her2-amplified-mutated-advanced-non-small-cell-l-44565https://curecurrent.com/trials/longitudinal-evaluation-of-microbial-and-host-signatures-during-immunotherapy-for-lung-cancer-44566https://curecurrent.com/trials/palliative-radiotherapy-of-multiple-metastatic-sites-before-first-line-of-systemic-therapy-with-immune-checkpoint-inhibi-44567https://curecurrent.com/trials/application-of-methylation-markers-in-early-detection-and-mrd-monitoring-of-lung-cancer-44568https://curecurrent.com/trials/determine-trial-treatment-arm-04-trastuzumab-in-combination-with-pertuzumab-in-adult-paediatric-and-teenage-young-adult-44569https://curecurrent.com/trials/a-study-to-evaluate-pk-efficacy-and-safety-of-bat3306-plus-chemo-and-compare-with-keytruda-eu-us-in-participants-with-iv-44570https://curecurrent.com/trials/telehealth-shared-decision-making-coaching-for-lung-cancer-screening-in-primary-care-telescope-for-hispanics-44571https://curecurrent.com/trials/application-research-of-methylation-markers-in-early-stage-lung-cancer-patients-treated-with-co-ablation-system-therapy-44572https://curecurrent.com/trials/rapart-in-locally-advanced-non-small-cell-lung-cancer-patients-44573https://curecurrent.com/trials/7t-brain-mri-scan-for-micro-brain-metastasis-microbm-detection-for-patients-with-small-cell-lung-cancer-sclc-who-decline-44574https://curecurrent.com/trials/safefit-trial-virtual-clinics-to-deliver-universal-interventions-in-people-with-cancer-44575https://curecurrent.com/trials/a-study-of-shr-a2102-in-combination-with-other-anti-tumor-therapies-for-resectable-non-small-cell-lung-cancer-44576https://curecurrent.com/trials/an-exploratory-clinical-study-on-the-safety-and-efficacy-of-autologous-nk-cells-in-the-treatment-of-pulmonary-nodules-44577https://curecurrent.com/trials/effects-of-iloprost-on-pulmonary-oxygenation-in-obese-patients-during-one-lung-ventilation-44578https://curecurrent.com/trials/randomized-trial-comparing-standard-of-care-versus-immune-based-combination-in-relapsed-stage-iii-non-small-cell-lung-ca-44579https://curecurrent.com/trials/postoperative-pulmonary-function-assessment-based-on-deep-learning-study-44580https://curecurrent.com/trials/accuracy-between-transthoracal-needle-aspiration-ttna-techniques-in-suspected-lung-cancer-patients-44581https://curecurrent.com/trials/survival-analysis-and-prognostic-biomarker-exploration-of-postoperative-adjuvant-therapy-patterns-in-patients-with-non-s-44582https://curecurrent.com/trials/prospective-cohort-of-locally-advanced-and-metastatic-non-small-cell-lung-cancer-patients-with-activating-egfr-mutations-44583https://curecurrent.com/trials/the-effectiveness-and-safety-of-sbrt-in-the-treatment-of-patients-with-mplc-after-surgery-smile-44584https://curecurrent.com/trials/study-of-of-oxygen-nebulized-inhalation-egcg-in-cancer-patients-with-new-coronary-pneumonia-44585https://curecurrent.com/trials/a-study-to-evaluate-safety-and-efficacy-of-wsd0922-fu-combo-with-osimertinib-for-nsclc-44586https://curecurrent.com/trials/impact-of-a-process-optimizing-the-decision-to-continue-or-stop-cancer-treatments-in-patients-with-advanced-non-small-ce-44587https://curecurrent.com/trials/augmented-reality-assisted-lung-nodule-localization-a-multicentered-prospective-randomly-controlled-non-inferiority-tria-44588https://curecurrent.com/trials/in-vivo-lung-perfusion-for-pulmonary-metastases-of-sarcoma-44589https://curecurrent.com/trials/covid-19-vaccine-responsiveness-in-mm-and-waldenstrom-44590https://curecurrent.com/trials/a-study-of-osimertinib-based-adaptive-treatment-guided-by-ctdna-egfrm-monitoring-in-nsclc-44591https://curecurrent.com/trials/datopotamab-deruxtecan-dato-dxd-ds-1062a-in-advanced-and-or-unresectable-non-small-cell-lung-cancer-44592https://curecurrent.com/trials/near-infrared-perfusion-during-minimally-invasive-thoracic-surgery-download-44593https://curecurrent.com/trials/a-safety-and-efficacy-study-evaluating-ctx131-in-adult-subjects-with-relapsed-or-refractory-solid-tumors-44594https://curecurrent.com/trials/adjuvant-chemotherapy-for-high-risk-pathologic-stage-i-non-squamous-nsclc-44595https://curecurrent.com/trials/keymaker-u01-substudy-2-efficacy-and-safety-study-of-pembrolizumab-mk-3475-when-used-with-investigational-agents-in-trea-44596https://curecurrent.com/trials/impact-of-perioperative-body-temperature-on-postoperative-complications-and-pain-in-video-assisted-thoracoscopic-surgery-44597https://curecurrent.com/trials/real-world-first-line-sugemalimab-chemotherapy-in-advanced-nsclc-44598https://curecurrent.com/trials/a-study-of-lorlatinib-versus-crizotinib-in-first-line-treatment-of-patients-with-alk-positive-nsclc-44599https://curecurrent.com/trials/platinum-doublet-chemotherapy-and-proton-beam-radiation-therapy-in-treating-patients-with-stage-ii-iii-non-small-cell-lu-44600https://curecurrent.com/trials/inherit-egfr-studying-germline-egfr-mutations-44601https://curecurrent.com/trials/real-time-monitoring-of-symptoms-in-lung-cancer-patients-receiving-oral-targeted-therapies-44602https://curecurrent.com/trials/study-of-niraparib-tsr-022-bevacizumab-and-platinum-based-doublet-chemotherapy-in-combination-with-tsr-042-44603https://curecurrent.com/trials/a-study-of-ivonescimab-in-first-line-es-sclc-44604https://curecurrent.com/trials/a-study-of-bl-m24d1-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-and-other-solid-tumors-44605https://curecurrent.com/trials/study-on-the-diagnosis-of-ground-glass-lung-cancer-by-microwave-ablation-combined-with-puncture-biopsy-44606https://curecurrent.com/trials/clinical-study-on-using-tcr-to-predict-the-effect-of-tislelizumab-chemotherapy-in-the-first-line-treatment-of-es-sclc-44607https://curecurrent.com/trials/study-to-evaluate-lb-lr1109-administered-alone-for-the-treatment-of-solid-tumor-and-in-combination-with-atezolizumab-for-44608https://curecurrent.com/trials/power-study-prospective-transbronchial-microwave-robotic-assisted-bronchoscopy-44609https://curecurrent.com/trials/a-study-of-gv20-0251-in-advanced-or-refractory-solid-tumors-44610https://curecurrent.com/trials/implementing-fragmentomics-into-real-world-screening-interventions-to-evaluate-clinical-utility-among-individuals-with-e-44611https://curecurrent.com/trials/a-study-of-participants-with-advanced-non-small-cell-lung-cancer-treated-with-nivolumab-in-france-after-at-least-one-pri-44612https://curecurrent.com/trials/determine-trial-treatment-arm-05-vemurafenib-in-combination-with-cobimetinib-in-adult-patients-with-braf-positive-cancer-44613https://curecurrent.com/trials/patient-centered-optimal-integration-of-survivorship-and-palliative-care-44614https://curecurrent.com/trials/is-3d-modeling-from-non-contrast-ct-accurate-for-minimally-invasive-lung-segmentectomies-44615https://curecurrent.com/trials/synthetic-pet-from-ct-improves-precision-diagnosis-and-treatment-of-lung-cancer-a-prospective-observational-multicenter-44616https://curecurrent.com/trials/implementing-tobacco-treatment-in-low-dose-ct-lung-cancer-screening-sites-44617https://curecurrent.com/trials/fitness-and-lung-function-among-survivors-of-heart-transplant-leukemia-and-infant-bpd-through-exercise-44618https://curecurrent.com/trials/multimodal-model-predicts-treatment-efficacy-and-cip-risk-in-advanced-nsclc-with-immunotherapy-and-chemotherapy-44619https://curecurrent.com/trials/a-study-of-nivolumab-in-participants-with-locally-advanced-or-metastatic-stage-iiib-iv-non-small-cell-lung-cancer-nsclc-44620https://curecurrent.com/trials/tc-d101-cell-therapy-for-patients-with-dll3-positive-sclc-44621https://curecurrent.com/trials/ai-assisted-detection-of-chest-x-rays-44622https://curecurrent.com/trials/lung-cancer-risk-and-early-detection-in-firefighters-44623https://curecurrent.com/trials/sac-tmt-plus-bevacizumab-as-second-line-treatment-for-advanced-non-squamous-non-small-cell-lung-cancer-44624https://curecurrent.com/trials/the-inspire-lung-study-44625https://curecurrent.com/trials/phase-3-trial-of-jmkx001899-versus-docetaxel-in-previously-treated-advanced-or-metastatic-kras-g12c-mutant-nsclc-44626https://curecurrent.com/trials/study-of-durvalumab-tremelimumab-durvalumab-and-placebo-in-limited-stage-small-cell-lung-cancer-in-patients-who-have-not-44627https://curecurrent.com/trials/high-dose-furmonertinib-or-combined-with-chemotherapy-in-egfr-mutant-advanced-nsclc-after-disease-progression-on-third-g-44628https://curecurrent.com/trials/circulating-immune-markers-for-prognostic-evaluation-in-postoperative-lung-cancer-patients-44629https://curecurrent.com/trials/informing-the-adaptation-of-a-chw-model-to-facilitate-lung-cancer-screening-for-the-chinese-community-44630https://curecurrent.com/trials/a-phase-1-2a-study-of-db-1311-bnt324-in-advanced-metastatic-solid-tumors-44631https://curecurrent.com/trials/trastuzumab-deruxtecan-in-participants-with-her2-mutated-metastatic-non-small-cell-lung-cancer-nsclc-44632https://curecurrent.com/trials/ivonescimab-monotherapy-or-in-combination-with-chemotherapy-as-neoadjuvant-adjuvant-therapy-for-resectable-non-small-cel-44633https://curecurrent.com/trials/supportive-care-intervention-roar-lct-for-patients-with-stage-iiia-iiib-and-iv-lung-cancer-roar-lct-trial-44634https://curecurrent.com/trials/a-study-of-hfb200301-as-a-single-agent-and-in-combination-with-tislelizumab-in-adult-patients-with-advanced-solid-tumors-44635https://curecurrent.com/trials/joint-thoracic-oncology-research-unit-of-lyon-lung-cancers-database-ulysse-44636https://curecurrent.com/trials/to-evaluate-the-efficacy-and-safety-of-anlotinib-hydrochloride-capsule-in-postoperative-non-pcr-patients-with-non-small-44637https://curecurrent.com/trials/intestinal-low-dose-radiotherapy-combined-with-immunotherapy-in-immune-resistant-metastatic-malignant-solid-tumors-44638https://curecurrent.com/trials/cognition-and-patients-with-lung-cancer-44639https://curecurrent.com/trials/involvement-of-general-practitioners-in-lung-cancer-screening-44640https://curecurrent.com/trials/development-of-a-new-tool-for-dyspnea-measurement-in-chronic-respiratory-diseases-44641https://curecurrent.com/trials/treatment-of-multifocal-lung-adenocarcinoma-44642https://curecurrent.com/trials/pet-ct-guided-antifungal-stewardship-in-invasive-pulmonary-aspergillosis-44643https://curecurrent.com/trials/study-to-assess-the-effect-of-azd9291-on-the-blood-levels-of-simvastatin-in-patients-with-egfrm-nsclc-44644https://curecurrent.com/trials/truthful-information-on-chemotherapy-and-its-impact-on-chemotherapy-at-the-end-of-life-44645https://curecurrent.com/trials/generation-of-reactive-t-cells-based-on-tumor-whole-cell-antigen-nanovaccines-44646https://curecurrent.com/trials/firmonertinib-in-the-treatment-of-egfr-nsclc-patients-with-central-nervous-system-metastasis-44647https://curecurrent.com/trials/electroacupuncture-combined-with-pd-1-inhibitor-for-ecog2-advanced-nsclc-44648https://curecurrent.com/trials/a-clinical-trial-of-tqb2102-for-injection-in-non-small-cell-lung-cancer-with-her2-gene-abnormality-44649https://curecurrent.com/trials/expanded-access-use-of-cemiplimab-in-patients-with-solid-tumors-44650https://curecurrent.com/trials/study-to-assess-the-effect-of-itraconazole-a-cyp3a4-inhibitor-on-the-pharmacokinetics-of-azd9291-in-patients-with-egfr-p-44651https://curecurrent.com/trials/study-of-ctdna-as-prognostic-factor-on-resectable-stage-iiia-nsclc-patients-treated-with-neoadjuvant-treatment-44652https://curecurrent.com/trials/ensartinib-after-chemoradiotherapy-in-stage-iii-alk-mutated-nsclc-44653https://curecurrent.com/trials/til-therapy-in-non-small-cell-lung-cancer-nsclc-patients-44654https://curecurrent.com/trials/palace-cemiplimab-trial-according-to-ctdna-levels-44655https://curecurrent.com/trials/neoadjuvant-treatment-with-atezolizumab-and-atezolizumab-as-maintenance-for-the-treatment-of-stage-iii-non-small-cell-lu-44656https://curecurrent.com/trials/the-effect-of-calisthenic-exercises-on-fatigue-and-exercise-attitudes-in-patients-with-lung-cancer-44657https://curecurrent.com/trials/study-evaluating-safety-tolerability-and-pharmacokinetics-pk-of-tarlatamab-in-adults-with-small-cell-lung-cancer-sclc-44658https://curecurrent.com/trials/combination-of-paclitaxel-bevacizumab-atezolizumab-in-patients-with-advanced-nsclc-progressing-after-immunotherapy-chemo-44659https://curecurrent.com/trials/double-immune-checkpoint-inhibitors-in-pd-l1-positive-stage-iv-non-small-lung-cancer-44660https://curecurrent.com/trials/interventional-ai-human-collaboration-for-liver-tumor-diagnosis-44661https://curecurrent.com/trials/atezolizumab-in-elderly-patients-with-advanced-non-small-cell-lung-cancer-and-receiving-carboplatin-paclitaxel-chemother-44662https://curecurrent.com/trials/phase-iii-study-of-shr-8068-combined-with-adebrelimab-and-chemotherapy-versus-tislelizumab-combined-with-chemotherapy-in-44663https://curecurrent.com/trials/neoadjuvant-sbrt-and-tislelizumab-immunotherapy-plus-anlotinib-for-resectable-egfr-wild-type-nsclc-44664https://curecurrent.com/trials/atezolizumab-plus-8-gy-single-fraction-radiotherapy-for-advanced-oligoprogressive-nsclc-44665https://curecurrent.com/trials/early-specialized-cardiovascular-intervention-based-on-impedance-cardiography-in-locally-advanced-non-small-cell-lung-ca-44666https://curecurrent.com/trials/lung-cancer-with-copanlisib-and-durvalumab-44667https://curecurrent.com/trials/study-of-erlotinib-tarceva-in-combination-with-osi-906-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-with-a-44668https://curecurrent.com/trials/percutaneous-image-guided-video-assisted-thoracic-surgery-vats-resection-of-lung-lesions-44669https://curecurrent.com/trials/phase-2-study-of-maintenance-osi-906-plus-erlotinib-tarceva-or-placebo-plus-erlotinib-in-patients-with-nonprogression-fo-44670https://curecurrent.com/trials/a-study-of-ql1706-in-combination-with-chemotherapy-in-pd-l1-negative-non-small-cell-lung-cancer-44671https://curecurrent.com/trials/physical-activity-coaching-after-surgery-for-patients-with-resectable-non-small-cell-lung-cancer-44672https://curecurrent.com/trials/phase-ii-clinical-study-of-shr2554-tablets-combined-with-other-anti-tumor-treatments-in-non-small-cell-lung-cancer-subje-44673https://curecurrent.com/trials/open-label-multicenter-real-world-practice-of-durvalumab-imfinzi-pms-44674https://curecurrent.com/trials/a-study-of-bl-m07d1-vs-pembrolizumab-platinum-chemotherapy-in-first-line-treatment-of-her2-mutant-advanced-or-metastatic-44675https://curecurrent.com/trials/study-of-bevacizumab-in-combination-with-chemoimmunotherapy-and-atezolizumab-in-patients-with-extensive-stage-small-cell-44676https://curecurrent.com/trials/study-of-safety-and-efficacy-of-brigatinib-plus-chemotherapy-or-brigatinib-only-in-advanced-alk-positive-lung-cancer-mas-44677https://curecurrent.com/trials/elimination-of-ptv-margins-based-on-mri-guided-adaptive-stereotactic-radiotherapy-for-non-small-cell-lung-cancer-with-br-44678https://curecurrent.com/trials/a-phase-ib-ii-clinical-study-to-evaluate-hlx43-in-combination-with-serplulimab-in-patients-with-advanced-metastatic-soli-44679https://curecurrent.com/trials/a-study-of-sot101-in-combination-with-pembrolizumab-to-evaluate-the-efficacy-and-safety-in-patients-with-selected-advanc-44680https://curecurrent.com/trials/dose-escalation-study-of-zg006-in-participants-with-advanced-small-cell-lung-cancer-or-neuroendocrine-carcinoma-followed-44681https://curecurrent.com/trials/docetaxel-with-or-without-bintrafusp-alfa-for-the-treatment-of-advanced-non-small-cell-lung-cancer-44682https://curecurrent.com/trials/a-dose-escalation-and-dose-expansion-phase-i-phase-ii-clinical-study-of-dositinib-mesylate-tablets-90-1408-in-the-treatm-44683https://curecurrent.com/trials/a-screening-study-to-collect-samples-for-taa-hla-hla-loss-of-heterozygosity-in-patients-with-metastatic-solid-tumors-44684https://curecurrent.com/trials/a-study-of-mhb036c-combined-with-anti-tumor-therapies-in-patients-with-advanced-lung-cancer-44685https://curecurrent.com/trials/elimination-of-ptv-margins-based-on-online-adaptive-stereotactic-radiotherapy-for-early-stage-non-small-cell-lung-cancer-44686https://curecurrent.com/trials/phase-1-2a-study-of-sq3370-in-patients-with-advanced-solid-tumors-44687https://curecurrent.com/trials/a-multicenter-study-to-evaluate-the-cios-spin-and-the-ion-endoluminal-system-for-pulmonary-nodule-biopsy-44688https://curecurrent.com/trials/image-guided-vats-vs-vats-resection-44689https://curecurrent.com/trials/study-to-evaluate-the-safety-pharmacokinetics-and-activity-of-gdc-1971-in-combination-with-either-osimertinib-in-partici-44690https://curecurrent.com/trials/stereotactic-magnetic-resonance-guided-radiation-therapy-44691https://curecurrent.com/trials/nivolumab-in-combination-with-plinabulin-in-patients-with-metastatic-non-small-cell-lung-cancer-nsclc-44692https://curecurrent.com/trials/an-investigational-scan-me-4fdg-pet-ct-for-the-detection-of-sodium-glucose-transport-for-early-diagnosis-of-lung-cancer-44693https://curecurrent.com/trials/tg4010-and-nivolumab-in-patients-with-lung-cancer-44694https://curecurrent.com/trials/talazoparib-and-low-dose-temozolomide-in-treating-participants-with-relapsed-or-refractory-extensive-stage-small-cell-lu-44695https://curecurrent.com/trials/real-time-image-guided-lymphatic-mapping-and-nodal-targeting-in-lung-cancer-44696https://curecurrent.com/trials/a-study-to-test-different-doses-of-bi-836880-combined-with-ezabenlimab-in-patients-with-advanced-non-small-cell-lung-can-44697https://curecurrent.com/trials/phase-i-ii-study-of-autologous-t-cells-to-express-t-cell-receptors-tcrs-in-subjects-with-solid-tumors-44698https://curecurrent.com/trials/feasibility-safety-and-efficacy-of-stereotactic-mri-guided-adaptive-radiation-therapy-smart-for-central-lung-tumors-44699https://curecurrent.com/trials/evaluating-a-fasting-mimicking-diet-in-combination-with-immunotherapy-in-patients-with-non-small-cell-lung-cancer-44700https://curecurrent.com/trials/study-of-arry-614-plus-either-nivolumab-or-nivolumab-ipilimumab-44701https://curecurrent.com/trials/phase-ii-study-of-pembrolizumab-after-curative-intent-treatment-for-oligometastatic-non-small-cell-lung-cancer-44702https://curecurrent.com/trials/radical-radiotherapy-and-immunotherapy-for-metastatic-cancer-of-the-lung-rradical-44703https://curecurrent.com/trials/a-study-of-lorlatinib-in-alk-inhibitor-treated-alk-positive-nsclc-in-china-44704https://curecurrent.com/trials/study-of-telisotuzumab-vedotin-abbv-399-in-participants-with-previously-treated-c-met-non-small-cell-lung-cancer-44705https://curecurrent.com/trials/study-of-osimertinib-and-stereotactic-ablative-radiation-sabr-in-egfr-mutant-nsclc-44706https://curecurrent.com/trials/tas-102-in-extrapulmonary-neuroendocrine-carcinoma-44707https://curecurrent.com/trials/an-open-label-dose-escalation-dose-expansion-safety-study-of-incb059872-in-subjects-with-advanced-malignancies-44708https://curecurrent.com/trials/a-safety-study-of-212pb-vmt-alpha-net-in-patients-with-neuroendocrine-tumors-44709https://curecurrent.com/trials/vorolanib-atezolizumab-as-maintenance-therapy-for-extensive-stage-small-cell-lung-cancer-44710https://curecurrent.com/trials/local-consolidative-therapy-and-brigatinib-in-treating-patients-with-stage-iv-or-recurrent-non-small-cell-lung-cancer-44711https://curecurrent.com/trials/study-of-regn5093-m114-metxmet-antibody-drug-conjugate-in-adult-patients-with-mesenchymal-epithelial-transition-factor-m-44712https://curecurrent.com/trials/pivotal-open-label-randomized-study-of-radiosurgery-with-or-without-tumor-treating-fields-ttfields-for-1-10-brain-metast-44713https://curecurrent.com/trials/phase-1-trial-of-endobronchial-ultrasound-guided-transbronchial-needle-injection-of-cisplatin-for-stage-iv-lung-cancer-44714https://curecurrent.com/trials/palliative-radiotherapy-with-lurbinectedin-in-patients-with-extensive-stage-small-cell-lung-cancer-44715https://curecurrent.com/trials/pembro-chemo-in-brain-mets-44716https://curecurrent.com/trials/remote-monitoring-in-cancer-care-a-platform-study-44717https://curecurrent.com/trials/an-investigational-immuno-therapy-trial-of-nivolumab-or-nivolumab-plus-ipilimumab-or-nivolumab-plus-platinum-doublet-che-44718https://curecurrent.com/trials/developing-a-shared-decision-making-tool-for-patients-with-surgically-removed-non-small-cell-lung-cancer-44719https://curecurrent.com/trials/a-clinical-study-of-bemcentinib-with-standard-of-care-chemoimmunotherapy-in-untreated-advanced-metastatic-non-small-cell-44720https://curecurrent.com/trials/biology-of-young-lung-cancer-study-the-young-lung-study-44721https://curecurrent.com/trials/study-of-df9001-in-patients-with-advanced-solid-tumors-44722https://curecurrent.com/trials/study-to-assess-adverse-events-and-change-in-disease-activity-in-adult-participants-with-advanced-solid-tumors-receiving-44723https://curecurrent.com/trials/tusamitamab-ravtansine-sar408701-in-combination-with-pembrolizumab-and-tusamitamab-ravtansine-sar408701-in-combination-w-44724https://curecurrent.com/trials/clinical-utility-of-portable-dynamic-chest-x-ray-ddr-in-the-icu-44725https://curecurrent.com/trials/anti-pd-l1-in-stage-iiia-n2-non-small-cell-lung-cancer-nsclc-44726https://curecurrent.com/trials/a-study-of-tsr-022-in-participants-with-advanced-solid-tumors-amber-44727https://curecurrent.com/trials/phase-ii-umbrella-study-of-novel-anti-cancer-agents-in-participants-with-nsclc-who-progressed-on-an-anti-pd-1-pd-l1-cont-44728https://curecurrent.com/trials/a-study-to-assess-the-safety-pharmacokinetics-and-efficacy-of-intravenous-iv-abbv-303-as-monotherapy-and-in-combination-44729https://curecurrent.com/trials/exercise-therapy-in-cancer-patients-who-are-recovering-from-covid-19-44730https://curecurrent.com/trials/atezolizumab-and-stereotactic-body-radiation-therapy-in-treating-patients-with-non-small-cell-lung-cancer-44731https://curecurrent.com/trials/a-study-assessing-kb707-for-the-treatment-of-advanced-solid-tumor-malignancies-affecting-the-lungs-44732https://curecurrent.com/trials/a-study-to-assess-disease-activity-of-intravenously-iv-infused-telisotuzumab-vedotin-in-adult-participants-with-advanced-44733https://curecurrent.com/trials/detection-of-genetic-markers-of-lung-cancer-44734https://curecurrent.com/trials/a-fih-study-of-pf-07284890-in-participants-with-braf-v600-mutant-solid-tumors-with-and-without-brain-involvement-44735https://curecurrent.com/trials/korea-osimertinib-real-world-evidence-study-to-assess-safety-and-efficacy-plus-44736https://curecurrent.com/trials/personalized-neoantigen-vaccine-in-combination-with-durvalumab-medi4736-in-extensive-stage-small-cell-lung-cancer-44737https://curecurrent.com/trials/recombinant-ephb4-hsa-fusion-protein-and-pembrolizumab-mk-3475-44738https://curecurrent.com/trials/a-study-of-zw171-in-participants-with-advanced-or-metastatic-mesothelin-expressing-cancers-44739https://curecurrent.com/trials/to-evaluate-efficacy-and-safety-of-serplulimab-chemotherapy-carboplatin-etoposide-in-us-patients-with-es-sclc-44740https://curecurrent.com/trials/azacitidine-combined-with-pembrolizumab-and-epacadostat-in-subjects-with-advanced-solid-tumors-echo-206-44741https://curecurrent.com/trials/study-of-the-immune-response-of-muc1-mucin1-peptide-vaccine-for-non-small-cell-lung-cancer-44742https://curecurrent.com/trials/a-study-of-selpercatinib-ly3527723-in-participants-with-advanced-or-metastatic-ret-fusion-positive-non-small-cell-lung-c-44743https://curecurrent.com/trials/study-of-pulsar-ici-imsa101-in-patients-with-oligometastatic-nsclc-and-rcc-44744https://curecurrent.com/trials/quality-of-life-intervention-to-inform-patient-decision-making-in-early-stage-lung-cancer-44745https://curecurrent.com/trials/phase-ii-of-neoadjuvant-and-adjuvant-capmatinib-in-nsclc-44746https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-incb099318-in-participants-with-advanced-solid-tumors-44747https://curecurrent.com/trials/prt3789-monotherapy-and-in-combo-w-docetaxel-in-participants-w-advanced-or-metastatic-solid-tumors-w-smarca4-mutation-44748https://curecurrent.com/trials/erlotinib-with-or-without-hydroxychloroquine-in-chemo-naive-advanced-nsclc-and-egfr-mutations-44749https://curecurrent.com/trials/a-phase-1-study-evaluating-the-safety-tolerability-and-efficacy-of-amg-119-in-subjects-with-rr-sclc-44750https://curecurrent.com/trials/osimertinib-monotherapy-or-combination-with-chemotherapy-for-advanced-nsclc-concurrent-egfr-and-tp53-mutations-44751https://curecurrent.com/trials/predicting-responsiveness-in-oncology-patients-based-on-host-response-evaluation-during-anti-cancer-treatments-44752https://curecurrent.com/trials/osimertinib-plus-chemotherapy-in-uncommon-egfrm-nsclc-44753https://curecurrent.com/trials/health-opportunities-and-promoters-of-equitable-screening-for-lung-cancer-44754https://curecurrent.com/trials/phase-ii-clinical-trial-of-nivo-ipi-taxane-in-untreated-metastatic-nsclc-44755https://curecurrent.com/trials/exalt3-study-comparing-x-396-ensartinib-to-crizotinib-in-alk-positive-non-small-cell-lung-cancer-nsclc-patients-44756https://curecurrent.com/trials/bewell360-cg-care-model-health-and-wellness-coaching-to-support-caregivers-of-patients-living-with-advanced-lung-cancers-44757https://curecurrent.com/trials/identification-of-prognostic-biomarkers-for-progression-of-invasive-squamous-cell-carcinoma-44758https://curecurrent.com/trials/long-term-safety-outcomes-and-first-line-treatment-patterns-in-patients-with-non-small-cell-lung-cancer-and-programmed-d-44759https://curecurrent.com/trials/q702-for-the-treatment-of-patients-with-hematologic-malignancies-44760https://curecurrent.com/trials/a-phase-1-study-to-evaluate-the-pharmacokinetics-of-jdq443-in-participants-with-hepatic-impairment-compared-to-matched-h-44761https://curecurrent.com/trials/prolonged-air-leak-pal-autologous-blood-patch-intervention-trial-44762https://curecurrent.com/trials/evaluating-the-feasibility-and-preliminary-effects-of-be-44763https://curecurrent.com/trials/a-study-to-assess-the-safety-and-efficacy-of-azd7789-in-participants-with-advanced-or-metastatic-solid-cancer-44764https://curecurrent.com/trials/intraoperative-paravertebral-block-and-postoperative-complications-44765https://curecurrent.com/trials/benson-relaxation-exercises-and-sleep-quality-in-lung-cancer-patients-44766https://curecurrent.com/trials/a-phase-1-safety-tolerability-and-pharmacokinetics-study-of-amg-794-with-claudin-6-positive-non-small-cell-lung-cancer-e-44767https://curecurrent.com/trials/tumor-cell-and-dna-detection-in-the-blood-urine-and-bone-marrow-44768https://curecurrent.com/trials/radiation-prior-to-tki-to-delay-progression-in-advanced-driver-mutated-non-small-cell-lung-cancers-radiance-lung-x-44769https://curecurrent.com/trials/metformin-for-chemoprevention-of-lung-cancer-in-overweight-or-obese-individuals-at-high-risk-for-lung-cancer-44770https://curecurrent.com/trials/bpi-361175-tablets-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-44771https://curecurrent.com/trials/a-randomized-trial-of-surgical-decision-making-guided-by-tdtp-recist-44772https://curecurrent.com/trials/response-and-toxicity-prediction-by-microbiome-analysis-after-concurrent-chemoradiotherapy-44773https://curecurrent.com/trials/a-study-of-orally-administered-jbi-802-alone-or-in-combination-with-pembrolizumab-for-patients-with-non-small-cell-lung-44774https://curecurrent.com/trials/observational-study-in-patients-with-previously-unresectable-malignant-pleural-mesothelioma-treated-with-nivolumab-and-i-44775https://curecurrent.com/trials/immunotherapy-in-patient-with-poor-general-condition-44776https://curecurrent.com/trials/testing-the-addition-of-an-anti-cancer-drug-entinostat-to-the-usual-chemotherapy-and-immunotherapy-treatment-atezolizuma-44777https://curecurrent.com/trials/penfluridol-for-relapsed-refractory-small-cell-cancers-44778https://curecurrent.com/trials/safety-and-preliminary-effectiveness-of-bgb-a445-in-combination-with-tislelizumab-in-participants-with-advanced-solid-tu-44779https://curecurrent.com/trials/multi-omics-molecular-characteristics-and-immunophenotyping-of-lung-signet-ring-cell-carcinoma-44780https://curecurrent.com/trials/hanse-holistic-implementation-study-assessing-a-northern-german-interdisciplinary-lung-cancer-screening-effort-44781https://curecurrent.com/trials/autoantibodies-against-type-i-interferon-in-patients-affected-with-ph-negative-myeloproliferative-neoplasms-mpn-ifn-stud-44782https://curecurrent.com/trials/intrathecal-double-checkpoint-inhibition-44783https://curecurrent.com/trials/the-ivo-lung-study-44784https://curecurrent.com/trials/cea-targeted-car-t-therapy-in-cea-positive-advanced-solid-tumors-44785https://curecurrent.com/trials/dc-nk-cell-therapy-44786https://curecurrent.com/trials/tovorafenib-day101-monotherapy-for-patients-with-melanoma-and-other-solid-tumors-44787https://curecurrent.com/trials/a-study-of-sar444245-combined-with-other-anticancer-therapies-for-the-treatment-of-participants-with-lung-cancer-or-meso-44788https://curecurrent.com/trials/study-of-plasma-ngs-for-assessment-characterization-evaluation-of-patients-with-alk-resistance-44789https://curecurrent.com/trials/a-trial-of-gfh018-and-toripalimab-in-combination-with-concurrent-chemoradiotherapy-in-stage-iii-nsclc-chemoradiotherapy-44790https://curecurrent.com/trials/a-phase-ii-study-of-ql1706-and-platinum-based-chemotherapy-in-patients-with-smarca4-deficient-locally-advanced-or-metast-44791https://curecurrent.com/trials/articugrasp-trial-new-flexible-tool-vs-standard-grasper-for-lung-cancer-node-removal-in-keyhole-chest-surgery-44792https://curecurrent.com/trials/thoracic-radiotherapy-plus-maintenance-durvalumab-after-first-line-carboplatin-and-etoposide-plus-durvalumab-in-extensiv-44793https://curecurrent.com/trials/assessment-of-tobacco-smoking-and-alcohol-drinking-and-treatment-outcomes-among-patients-with-lung-or-head-and-neck-canc-44794https://curecurrent.com/trials/what-is-the-impact-of-tki-on-thyroid-function-in-cml-patients-44795https://curecurrent.com/trials/evaluate-the-efficacy-and-safety-of-serplulimab-plus-chemotherapy-in-neoadjuvant-and-adjuvant-treatment-of-resectable-ns-44796https://curecurrent.com/trials/phase-2-trial-of-afatinib-plus-prednisone-for-advanced-squamous-nsclc-44797https://curecurrent.com/trials/study-of-tpx-0022-in-patients-with-advanced-nsclc-gastric-cancer-or-solid-tumors-harboring-genetic-alterations-in-met-44798https://curecurrent.com/trials/a-study-of-apg-1252-plus-osimertinib-azd9291-in-egfr-tki-resistant-nsclc-patients-44799https://curecurrent.com/trials/pragmatic-analysis-of-complex-radiotherapy-cases-in-cancer-of-the-lung-44800https://curecurrent.com/trials/nutricare-plus-a-medically-tailored-meal-intervention-among-patients-with-lung-cancer-44801https://curecurrent.com/trials/real-world-study-of-taletrectinib-in-advanced-ros1-nsclc-following-entrectinib-progression-44802https://curecurrent.com/trials/a-real-world-study-of-ibi351-for-kras-g12c-nsclc-in-china-44803https://curecurrent.com/trials/real-world-study-of-platinum-containing-dual-drug-chemotherapy-followed-by-large-fractionated-radiotherapy-combined-with-44804https://curecurrent.com/trials/sequential-chemotherapy-with-befotertinib-in-non-small-cell-lung-cancer-nsclc-patients-with-resistance-to-third-generati-44805https://curecurrent.com/trials/adebrelimab-plus-chemoradiotherapy-followed-by-adebrelimab-maintenance-in-limited-stage-sclc-44806https://curecurrent.com/trials/effects-of-essential-amino-acid-intake-on-net-protein-synthesis-in-weight-losing-non-small-cell-lung-cancer-patients-44807https://curecurrent.com/trials/study-on-the-mechanism-of-acquired-resistance-of-entrectinib-44808https://curecurrent.com/trials/open-label-biomarker-integrated-umbrella-trial-for-first-line-treatment-of-extensive-stage-small-cell-lung-cancer-44809https://curecurrent.com/trials/phase-ib-study-of-tno155-in-combination-with-spartalizumab-or-ribociclib-in-selected-malignancies-44810https://curecurrent.com/trials/a-study-of-bl-m02d1-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-or-other-solid-tumors-44811https://curecurrent.com/trials/intra-pemetrexed-plus-third-generation-small-molecule-tki-drugs-e-g-osimertinib-versus-third-generation-small-molecule-t-44812https://curecurrent.com/trials/clinical-efficacy-and-safety-of-microwave-ablation-combined-with-huaier-granules-in-patients-with-inoperable-stage-ia-no-44813https://curecurrent.com/trials/sacituzumab-tirumotecan-sac-tmt-plus-bevacizumab-in-3rd-generation-egfr-tki-treated-advanced-egfr-mutant-nonsquamous-nsc-44814https://curecurrent.com/trials/amg-757-and-amg-404-in-subjects-with-small-cell-lung-cancer-sclc-44815https://curecurrent.com/trials/si-b001-combined-with-osimertinib-mesylate-tablets-in-the-treatment-of-recurrent-metastatic-non-small-cell-lung-cancer-44816https://curecurrent.com/trials/si-b001-combined-with-chemotherapy-in-the-treatment-of-egfr-alk-wt-recurrent-or-metastatic-nsclc-44817https://curecurrent.com/trials/a-study-of-si-b003-and-bl-b01d1-si-b003-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-nasop-44818https://curecurrent.com/trials/a-study-of-es102-in-combination-with-toripalimab-in-subjects-with-advanced-non-small-cell-lung-cancer-44819https://curecurrent.com/trials/a-study-on-using-sfrt-with-standard-treatment-for-oligoprogressive-nsclc-44820https://curecurrent.com/trials/calypso-based-deep-inspiration-breath-hold-dibh-radiation-treatments-of-lung-cancer-44821https://curecurrent.com/trials/a-study-of-si-b001-an-egfr-her3-bispecific-antibody-in-locally-advanced-or-metastatic-epithelial-tumors-44822https://curecurrent.com/trials/exl01-in-combination-with-nivolumab-for-advanced-nsclc-refractory-to-immunotherapy-44823https://curecurrent.com/trials/prospective-study-to-evaluate-high-flow-nasal-cannula-with-monitored-anesthesia-care-during-ebus-bronchoscopy-44824https://curecurrent.com/trials/sacituzumab-tirumotecan-in-combination-with-furmonertinib-as-second-line-treatment-for-egfr-mutant-advanced-or-metastati-44825https://curecurrent.com/trials/carboplatin-etoposide-and-atezolizumab-with-or-without-trilaciclib-g1t28-a-cdk4-6-inhibitor-in-extensive-stage-sclc-44826https://curecurrent.com/trials/cab-axl-adc-safety-and-efficacy-study-in-adults-with-nsclc-44827https://curecurrent.com/trials/postbiotics-ameliorate-cachexia-in-patients-with-non-small-cell-lung-cancer-44828https://curecurrent.com/trials/trilaciclib-g1t28-in-patients-with-previously-treated-extensive-stage-sclc-receiving-topotecan-chemotherapy-44829https://curecurrent.com/trials/improving-cancer-on-treatment-symptom-management-44830https://curecurrent.com/trials/bemcentinib-bgb324-in-combination-with-pembrolizumab-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-44831https://curecurrent.com/trials/osimertinib-for-advanced-egfr-positive-nsclc-patients-44832https://curecurrent.com/trials/the-immunotherapy-pleural-5-ala-pdt-44833https://curecurrent.com/trials/a-dose-escalation-study-of-hbi-2438-in-patients-with-solid-tumors-harboring-kras-g12c-mutation-44834https://curecurrent.com/trials/immunodynamics-guided-optimization-of-individualized-immunochemotherapy-in-advanced-driver-negative-nsclc-a-randomized-t-44835https://curecurrent.com/trials/tislelizumab-combined-with-chemotherapy-and-relayed-radiotherapy-in-first-line-treatment-of-es-sclc-44836https://curecurrent.com/trials/doubled-doubling-outcomes-by-lung-cancer-early-diagnosis-44837https://curecurrent.com/trials/longitudinal-phenotyping-and-endotyping-study-in-adult-patients-with-mild-moderate-or-severe-asthma-44838https://curecurrent.com/trials/impact-of-dysbiosis-inducing-drugs-on-effectivity-of-immune-checkpoint-inhibitor-in-non-small-cell-lung-cancer-patients-44839https://curecurrent.com/trials/first-line-therapy-with-nivolumab-plus-ipilimumab-in-combination-with-chemotherapy-for-metatastatic-nsclc-nicrewo-trial-44840https://curecurrent.com/trials/cadonilimab-ak104-plus-concurrent-chemoradiotherapy-in-patients-with-locally-advanced-unresectable-stage-iii-nsclc-44841https://curecurrent.com/trials/lorlatinib-after-failure-of-first-line-tki-in-patients-with-advanced-ros1-positive-nsclc-albatros-44842https://curecurrent.com/trials/a-dose-escalation-study-of-shp2-inhibitor-in-patients-with-solid-tumors-harboring-kras-of-egfr-mutations-44843https://curecurrent.com/trials/the-role-of-dna-and-rna-in-ngs-analyses-for-advaced-stage-nsclc-patients-44844https://curecurrent.com/trials/a-study-to-evaluate-shr-1210-in-combination-with-famitinib-plus-chemotherapy-in-subjects-with-nsclc-44845https://curecurrent.com/trials/ebus-tbna-after-pet-ct-in-diagnosing-patients-with-stage-i-iia-non-small-cell-lung-cancer-evaluated-for-stereotactic-bod-44846https://curecurrent.com/trials/neoadjuvant-immunotherapy-in-early-stage-non-small-cell-lung-cancer-presenting-as-synchronous-ground-glass-nodules-44847https://curecurrent.com/trials/testing-the-safety-of-adding-either-monalizumab-iph2201-or-oleclumab-medi9447-to-durvalumab-medi4736-plus-standard-radia-44848https://curecurrent.com/trials/a-study-of-the-c-kit-specific-antibody-drug-conjugate-nn3201-for-advanced-and-or-metastatic-solid-tumors-known-to-expres-44849https://curecurrent.com/trials/perioperative-and-postoperative-circulating-tumor-cell-monitoring-in-different-stage-of-nsclc-44850https://curecurrent.com/trials/dual-energy-ct-a-tool-for-delineation-of-tumor-and-organs-at-risk-in-radiotherapy-44851https://curecurrent.com/trials/a-comparison-of-methods-for-assisting-needle-angle-selection-during-image-guided-tissue-biopsy-44852https://curecurrent.com/trials/a-study-of-hlx42-in-advanced-metastatic-solid-tumors-44853https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-in-participants-with-advanced-solid-tumors-mk-3475-158-keynote-158-44854https://curecurrent.com/trials/biomarkers-in-patients-with-respiratory-tract-dysplasia-or-lung-cancer-head-and-neck-cancer-or-aerodigestive-tract-cance-44855https://curecurrent.com/trials/expanding-access-to-home-based-palliative-care-44856https://curecurrent.com/trials/analysis-of-circulating-tumor-markers-in-blood-alcina-5-44857https://curecurrent.com/trials/benefits-study-of-respiratory-gated-pet-acquisition-in-lung-disease-44858https://curecurrent.com/trials/nintedanib-as-switch-maintenance-treatment-of-pleural-malignant-mesothelioma-44859https://curecurrent.com/trials/an-observational-study-on-the-assessment-of-lung-cancer-using-liquid-biopsy-for-collecting-mirna-expression-profile-and-44860https://curecurrent.com/trials/bi-1910-as-a-single-agent-and-in-combination-with-pembrolizumab-for-the-treatment-of-advanced-solid-tumors-44861https://curecurrent.com/trials/a-study-of-bl-b01d1-and-bl-b01d1-in-combination-with-osimertinib-mesylate-tablets-in-patients-with-locally-advanced-or-m-44862https://curecurrent.com/trials/study-of-ik-595-in-ras-or-raf-altered-advanced-tumors-44863https://curecurrent.com/trials/the-use-of-molecular-radiogenomics-in-non-small-cell-lung-cancer-44864https://curecurrent.com/trials/jyp0322-versus-platinum-based-doublet-chemotherapy-in-ros1-positive-patients-previously-treated-with-ros1-tkis-44865https://curecurrent.com/trials/clinical-effectiveness-assessment-of-veristrat-testing-and-validation-of-immunotherapy-tests-in-nsclc-subjects-44866https://curecurrent.com/trials/high-dose-firmonertinib-plus-bevacizumab-as-neoadjuvant-therapy-for-resectable-egfrm-stage-ii-iiib-nsclc-44867https://curecurrent.com/trials/radiograph-accelerated-detection-and-identification-of-cancer-in-the-lung-44868https://curecurrent.com/trials/sunset-sbrt-for-ultra-central-nsclc-a-safety-and-efficacy-trial-44869https://curecurrent.com/trials/assessment-of-precision-irradiation-in-early-nsclc-and-interstitial-lung-disease-44870https://curecurrent.com/trials/a-study-of-bl-m14d1-in-patients-with-locally-advanced-or-metastatic-small-cell-lung-cancer-neuroendocrine-tumors-and-oth-44871https://curecurrent.com/trials/liquid-biopsy-to-predict-responses-to-first-line-immunotherapy-in-metastatic-non-small-cell-lung-cancer-liberty-lung-44872https://curecurrent.com/trials/cobimetinib-in-refractory-langerhans-cell-histiocytosis-lch-and-other-histiocytic-disorders-44873https://curecurrent.com/trials/the-lungvision-navigational-platform-for-preoperative-labeling-of-pulmonary-ground-glass-nodules-with-fiducial-markers-44874https://curecurrent.com/trials/assessing-the-efficacy-and-safety-of-selective-metabolically-adaptive-radiation-dose-escalation-in-locally-advanced-non-44875https://curecurrent.com/trials/a-study-of-pf-07820435-as-a-single-agent-and-in-combination-in-participants-with-advanced-solid-tumors-44876https://curecurrent.com/trials/oncosweep-cancer-spotlight-and-spectrum-product-line-44877https://curecurrent.com/trials/analysis-of-deoxyribonucleic-acid-and-ribonucleic-acid-next-generation-sequencing-in-non-small-cell-lung-cancer-patients-44878https://curecurrent.com/trials/pembrolizumab-versus-chemotherapy-and-pembrolizumab-in-non-small-cell-lung-cancers-nsclc-with-pdl1-50-44879https://curecurrent.com/trials/monarch-robotic-bronchoscopy-for-lung-nodule-icg-dye-marking-before-vats-44880https://curecurrent.com/trials/needle-based-confocal-laser-endomicroscopy-for-diagnosis-of-lung-cancer-in-patients-with-peripheral-pulmonary-nodules-44881https://curecurrent.com/trials/clinical-registry-for-oligometastic-disease-consolidation-therapy-debulking-prior-to-chemotherapy-or-re-irradiation-44882https://curecurrent.com/trials/primary-tumor-resection-plus-osimertinib-in-advanced-egfr-mutant-non-small-cell-lung-cancer-44883https://curecurrent.com/trials/ph-i-ii-trial-of-systemic-vsv-ifn-nis-in-combination-with-checkpoint-inhibitor-therapy-in-patients-with-select-solid-tum-44884https://curecurrent.com/trials/ociperlimab-with-tislelizumab-and-chemotherapy-in-participants-with-untreated-metastatic-non-small-cell-lung-cancer-44885https://curecurrent.com/trials/primary-tumor-resection-with-sintilimab-and-chemotherapy-in-advanced-nsclc-44886https://curecurrent.com/trials/a-cell-free-dna-methylation-blood-based-test-for-biliary-tract-cancers-screening-44887https://curecurrent.com/trials/observational-study-to-evaluate-the-safety-and-efficacy-of-zepzelca-injection-44888https://curecurrent.com/trials/alg-lungcancerregistry-safro2202-44889https://curecurrent.com/trials/assessing-ai-for-detecting-lung-nodules-and-cancer-pre-and-post-deployment-study-44890https://curecurrent.com/trials/srs-for-nsclc-with-oligo-residual-intracranial-disease-after-first-line-3rd-generation-egfr-tki-44891https://curecurrent.com/trials/neoadjuvant-kras-g12c-directed-therapy-with-adagrasib-mrtx849-with-or-without-nivolumab-44892https://curecurrent.com/trials/first-line-immunotherapy-based-standard-of-care-and-local-ablative-treatments-for-oligometastatic-non-small-cell-lung-ca-44893https://curecurrent.com/trials/special-drug-use-results-surveillance-of-tabrecta-tablets-44894https://curecurrent.com/trials/serplulimab-combined-with-cryoablation-for-early-stage-non-small-cell-lung-cancer-44895https://curecurrent.com/trials/prospective-observational-study-on-es-sclc-44896https://curecurrent.com/trials/physical-functioning-throughout-lung-cancer-treatment-44897https://curecurrent.com/trials/sequencing-of-stereotactic-ablative-body-radiotherapy-in-combination-with-pd-1-blockade-using-pembrolizumab-in-metastati-44898https://curecurrent.com/trials/a-real-world-study-of-adebrelimab-based-combination-regimens-in-the-treatment-of-advanced-solid-tumors-44899https://curecurrent.com/trials/deciphering-mechanisms-underlying-cancer-immunogenicity-44900https://curecurrent.com/trials/predictive-value-of-cea-and-ctdna-in-lung-cancer-recurrence-44901https://curecurrent.com/trials/human-papillomavirus-and-cervical-dysplasia-in-women-with-cystic-fibrosis-44902https://curecurrent.com/trials/a-study-of-brigatinib-compared-to-alectinib-in-adults-with-non-small-cell-lung-cancer-44903https://curecurrent.com/trials/segmentectomy-vs-lobectomy-for-2-3cm-iaslc-grade-1-2-lung-adenocarcinoma-a-multi-center-rct-44904https://curecurrent.com/trials/observational-study-on-the-impact-of-herpes-zoster-vaccine-on-the-incidence-of-herpes-zoster-and-survival-in-lung-cancer-44905https://curecurrent.com/trials/robotic-lobectomy-vs-thoracoscopic-lobectomy-for-early-stage-lung-cancer-rct-44906https://curecurrent.com/trials/phase-1a-1b-study-of-tpst-1495-as-a-single-agent-and-in-combination-with-pembrolizumab-in-subjects-with-solid-tumors-44907https://curecurrent.com/trials/fissios-and-postoperative-complications-fpoc-trial-44908https://curecurrent.com/trials/real-world-study-on-gene-profile-in-patients-with-advanced-nsclc-who-progressed-on-first-line-osimertinib-therapy-gps-44909https://curecurrent.com/trials/feasibility-of-immunotherapy-administration-to-patients-with-bronchial-cancer-in-a-hospital-at-home-setting-imhadom-44910https://curecurrent.com/trials/immunotherapy-clearance-and-phenotype-of-circulating-tumor-cells-in-lung-and-head-and-neck-cancers-44911https://curecurrent.com/trials/personalized-sbrt-in-early-stage-peripheral-nsclc-44912https://curecurrent.com/trials/observation-or-upfront-cranial-rt-in-oncogene-mutated-nsclc-with-asymptomatic-bm-a-phase-iii-rct-44913https://curecurrent.com/trials/a-study-of-aflibercept-versus-placebo-in-patients-with-second-line-docetaxel-for-locally-advanced-or-metastatic-non-smal-44914https://curecurrent.com/trials/concomitant-chemo-radiotherapy-in-locally-advanced-non-small-cell-lung-cancer-44915https://curecurrent.com/trials/first-line-treatment-in-egfr-mutation-positive-advanced-nsclc-patients-with-central-nervous-system-cns-metastases-44916https://curecurrent.com/trials/local-consolidative-radiation-therapy-plus-tki-versus-tki-alone-in-driver-mutated-om-nsclc-44917https://curecurrent.com/trials/taiwan-real-world-ldct-screening-behavior-and-outcome-research-for-high-risk-subjects-based-on-health-promotion-administ-44918https://curecurrent.com/trials/efficacy-of-neoadjuvant-immunotherapy-in-patients-with-lung-cancer-44919https://curecurrent.com/trials/a-study-evaluating-ab248-alone-or-in-combination-with-pembrolizumab-in-adult-patients-with-solid-tumors-44920https://curecurrent.com/trials/the-cardiac-stress-and-electrocardiographic-changes-caused-by-lung-cancer-surgery-44921https://curecurrent.com/trials/testing-c-raven-a-virtual-tobacco-cessation-intervention-in-the-community-44922https://curecurrent.com/trials/standard-maintenance-therapy-smt-vs-local-consolidative-radiation-therapy-and-smt-in-om-nsclc-44923https://curecurrent.com/trials/interest-of-intensive-postoperative-rehabilitation-following-minimally-invasive-lung-resection-44924https://curecurrent.com/trials/effectiveness-of-an-enhanced-tobacco-intervention-protocol-compared-to-standard-treatment-in-helping-head-and-neck-and-l-44925https://curecurrent.com/trials/a-study-on-the-efficacy-of-androgen-deprivation-therapy-combined-with-anti-pd-1-therapy-in-advanced-lung-cancer-44926https://curecurrent.com/trials/safety-and-efficacy-study-of-pemetrexed-platinum-chemotherapy-pembrolizumab-mk-3475-with-or-without-lenvatinib-mk-7902-e-44927https://curecurrent.com/trials/pharmacokinetic-study-of-ql2107-versus-keytruda-for-adjuvant-therapy-of-non-small-cell-lung-cancer-nsclc-44928https://curecurrent.com/trials/mobile-lung-cancer-screening-44929https://curecurrent.com/trials/ak112-in-non-squamous-non-small-cell-lung-cancer-nsclc-patients-with-actionable-genomic-alterations-aga-who-have-failed-44930https://curecurrent.com/trials/athletic-intervention-after-thoracic-surgery-for-lung-cancer-a-pilot-study-44931https://curecurrent.com/trials/immune-marker-platform-for-patients-with-advanced-lung-cancer-44932https://curecurrent.com/trials/dacomitinib-in-lung-cancer-with-uncommon-egfr-mutations-44933https://curecurrent.com/trials/assessment-of-tool-placement-in-pulmonary-nodule-s-using-a-robotic-navigational-bronchoscopy-system-44934https://curecurrent.com/trials/nanocrystalline-megestrol-acetate-in-concurrent-chemoradiotherapy-for-locally-advanced-non-small-cell-lung-cancer-44935https://curecurrent.com/trials/patients-with-es-sclc-and-ecog-ps-2-receiving-atezolizumab-carboplatin-etoposide-44936https://curecurrent.com/trials/thoracic-radiotherapy-for-patients-with-metastatic-stage-iv-non-small-cell-lung-cancer-at-high-risk-of-symptomatic-progr-44937https://curecurrent.com/trials/a-phase-i-ii-study-of-wj13404-monotherapy-in-patients-with-advanced-or-mentastatic-non-small-cell-lung-cancer-44938https://curecurrent.com/trials/pharmacogenomics-anda-snp-clinical-study-topotecan-and-single-nucleotide-polymorphisms-44939https://curecurrent.com/trials/a-study-to-assess-the-efficacy-of-wsd0922-fu-in-patients-with-c797s-advanced-non-small-cell-lung-cancer-44940https://curecurrent.com/trials/effect-of-transcutaneous-acupoint-electrical-stimulation-taes-on-postoperative-cough-in-lung-cancer-44941https://curecurrent.com/trials/vebreltinib-for-neoadjuvant-in-metex-14-skipping-mutant-stage-iia-iiib-n2-non-small-cell-lung-cancer-nsclc-44942https://curecurrent.com/trials/impact-of-maxigesic-on-delirium-after-minimally-invasive-lung-surgery-in-elderly-patients-44943https://curecurrent.com/trials/toripalimab-combined-with-cryoablation-for-first-line-oligo-progression-in-driver-negative-advanced-nsclc-44944https://curecurrent.com/trials/a-study-of-eli-002-in-subjects-with-kras-mutated-pancreatic-ductal-adenocarcinoma-pdac-and-other-solid-tumors-44945https://curecurrent.com/trials/a-study-of-hstc810-in-combination-with-paclitaxel-in-relapsed-or-refractory-extensive-stage-small-cell-lung-cancer-44946https://curecurrent.com/trials/fluid-biopsy-for-the-diagnosis-of-lung-cancer-44947https://curecurrent.com/trials/sirolimus-and-auranofin-in-treating-patients-with-advanced-or-recurrent-non-small-cell-lung-cancer-or-small-cell-lung-ca-44948https://curecurrent.com/trials/decision-aid-for-the-improvement-of-decision-making-in-patients-with-non-small-cell-lung-cancer-44949https://curecurrent.com/trials/a-feasibility-study-of-mri-guided-stereotactic-ablative-radiotherapy-midsection-44950https://curecurrent.com/trials/cancer-rapid-diagnostics-and-immune-assessment-for-sars-cov-2-covid-19-44951https://curecurrent.com/trials/a-study-of-morab-202-in-participants-with-previously-treated-metastatic-non-small-cell-lung-cancer-nsclc-adenocarcinoma-44952https://curecurrent.com/trials/bozitinib-combined-with-chemotherapy-as-radical-treatment-for-stage-iia-iiic-met-altered-non-small-cell-lung-cancer-44953https://curecurrent.com/trials/safety-and-efficacy-of-lorbrena-44954https://curecurrent.com/trials/a-study-to-evaluate-safety-efficacy-of-ff-10832-in-combo-with-pembrolizumab-in-urothelial-non-small-cell-lung-cancer-44955https://curecurrent.com/trials/community-exercise-treating-effect-on-cardiopulmonary-disease-patients-44956https://curecurrent.com/trials/patient-reported-outcome-measurements-proms-impact-on-clinical-outcome-in-first-line-setting-non-small-cell-lung-cancer-44957https://curecurrent.com/trials/an-open-label-phase-i-clinical-trial-of-super1-tcr-t-in-ny-eso-1-positive-patients-with-advanced-solid-tumors-44958https://curecurrent.com/trials/tumor-rebiopsy-during-progression-under-immunotherapy-for-patients-with-lung-cancer-44959https://curecurrent.com/trials/feasibility-of-rus-lung-in-mits-44960https://curecurrent.com/trials/jsi-1187-01-monotherapy-and-in-combination-with-dabrafenib-for-advanced-solid-tumors-with-mapk-pathway-mutations-44961https://curecurrent.com/trials/nebulized-inhalation-of-recombinant-human-p53-adenovirus-injection-for-treatment-of-multiple-ground-glass-lung-nodules-a-44962https://curecurrent.com/trials/realmove-lung-assessing-tumour-motion-with-dynamic-mri-44963https://curecurrent.com/trials/a-phase-1-2a-study-of-imm-1-104-in-participants-with-advanced-or-metastatic-solid-tumors-44964https://curecurrent.com/trials/characteristics-of-advanced-lung-cancer-at-the-time-of-diagnosis-in-a-large-italian-cohor-44965https://curecurrent.com/trials/community-support-program-for-lung-cancer-screening-44966https://curecurrent.com/trials/real-world-clinical-outcomes-of-patients-with-early-stage-lung-cancer-after-the-surgery-44967https://curecurrent.com/trials/preoperative-amivantamab-or-amivantamab-and-carboplatin-pemetrexed-treatment-in-patients-with-resectable-non-small-cell-44968https://curecurrent.com/trials/clinical-study-of-al2846-capsules-in-the-treatment-of-advanced-lung-tumor-and-advanced-ovarian-cancer-44969https://curecurrent.com/trials/tusamitamab-ravtansine-in-nsq-nsclc-participants-with-negative-or-moderate-ceacam5-expression-tumors-and-high-circulatin-44970https://curecurrent.com/trials/study-to-evaluate-the-safety-of-pembrolizumab-in-participants-with-unresectable-or-metastatic-melanoma-or-non-small-cell-44971https://curecurrent.com/trials/a-study-to-assess-the-efficacy-and-safety-of-wsd0922-fu-in-patients-with-egfrm-advanced-non-small-cell-lung-cancer-44972https://curecurrent.com/trials/an-open-prospective-longitudinal-pulmonary-cardiovascular-cohort-study-44973https://curecurrent.com/trials/surufatinib-plus-anti-pd-1-l1-as-maintenance-therapy-in-extensive-stage-small-cell-lung-cancer-44974https://curecurrent.com/trials/radiotherapy-strategies-for-use-in-combined-treatment-of-small-cell-lung-cancer-44975https://curecurrent.com/trials/a-study-to-evaluate-ab308-in-combination-with-ab122-in-participants-with-advanced-malignancies-44976https://curecurrent.com/trials/a-clinica-study-of-pyrotinib-in-patients-of-advanced-non-small-cell-lung-cancer-with-her2-mutation-44977https://curecurrent.com/trials/js001sc-or-js001-plus-chemotherapy-is-indicated-for-relapsed-or-metastatic-first-line-non-squamous-non-small-cell-lung-c-44978https://curecurrent.com/trials/phase-1-2-trial-of-gavo-cel-tc-210-in-patients-with-advanced-mesothelin-expressing-cancer-44979https://curecurrent.com/trials/atezolizumab-and-tiragolumab-in-patients-with-nsclc-or-advanced-solid-tumors-having-had-prior-treatment-with-a-pd-1-inhi-44980https://curecurrent.com/trials/chemotherapy-and-immunotherapy-in-extensive-stage-small-cell-lung-cancer-with-thoracic-radiotherapy-44981https://curecurrent.com/trials/an-umbrella-study-of-recurrent-extensive-stage-small-cell-lung-cancer-based-on-molecular-typing-44982https://curecurrent.com/trials/an-observational-study-on-the-impact-of-the-23-valent-pneumonia-vaccine-on-lung-cancer-patients-44983https://curecurrent.com/trials/slnd-or-not-in-ct1-ggo-invasive-lung-adenocarcinoma-ectop-1009-44984https://curecurrent.com/trials/ldct-sc-fi-low-dose-ct-screening-for-lung-cancer-44985https://curecurrent.com/trials/iparomlimab-and-tuvonralimab-plus-chemotherapy-for-inducing-conversion-to-resectability-in-initially-unresectable-stage-44986https://curecurrent.com/trials/a-phase-1-2-open-label-dose-escalation-safety-study-of-incagn01949-in-subjects-with-advanced-or-metastatic-solid-tumors-44987https://curecurrent.com/trials/dexamethasone-effects-in-patients-with-refractory-non-small-cell-lung-cancer-using-flt-positron-emission-tomography-44988https://curecurrent.com/trials/centralized-lung-cancer-early-detection-among-smokers-clear-study-44989https://curecurrent.com/trials/novel-thin-bronchoscope-versus-ultrathin-bronchoscope-for-the-diagnosis-of-peripheral-pulmonary-nodules-44990https://curecurrent.com/trials/a-study-of-bl-m09d1-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-and-other-solid-tumors-44991https://curecurrent.com/trials/study-to-investigate-luveltamab-tazevibulin-in-adults-with-advanced-or-metastatic-non-small-cell-lung-cancer-44992https://curecurrent.com/trials/can-2409-plus-prodrug-with-standard-of-care-immune-checkpoint-inhibitor-for-stage-iii-iv-nsclc-44993https://curecurrent.com/trials/pembrolizumab-plus-epacadostat-vs-pembrolizumab-plus-placebo-in-metastatic-non-small-cell-lung-cancer-keynote-654-05-ech-44994https://curecurrent.com/trials/ttfields-in-general-routine-clinical-care-in-patients-with-pleural-mesothelioma-study-44995https://curecurrent.com/trials/ql1706-bevacizumab-chemotherapy-in-post-ici-non-squamous-nsclc-44996https://curecurrent.com/trials/a-phase-i-ib-study-of-mek162-a-mek-inhibitor-in-combination-with-carboplatin-and-pemetrexed-in-patients-with-non-squamou-44997https://curecurrent.com/trials/real-world-stage-ii-iii-nsclc-patients-receiving-neoadjuvant-chemo-immunotherapy-and-no-surgical-resection-44998https://curecurrent.com/trials/irinotecan-liposome-combined-with-anlotinib-as-second-line-regimen-for-sclc-44999https://curecurrent.com/trials/a-study-of-al8326-in-healthy-subjects-45000